Page last updated: 2024-08-24

capecitabine and Colonic Neoplasms

capecitabine has been researched along with Colonic Neoplasms in 333 studies

Research

Studies (333)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (0.90)	18.2507
2000's	80 (24.02)	29.6817
2010's	178 (53.45)	24.3611
2020's	72 (21.62)	2.80

Authors

Authors	Studies
Liposits, G; Pfeiffer, P	1
Aggarwal, A; Boyle, JM; Braun, MS; Cowling, TE; Fearnhead, NS; Kuryba, A; van der Meulen, J; Walker, K	1
Aust, DE; Folprecht, G; Kraeft, AL; Kramer, M; Lugnier, C; Reinacher-Schick, A; Tannapfel, A; Thiede, C; von Bubnoff, N; Weiss, L; Weitz, J; Wisser, S	1
Liu, S; Sun, Z; Wu, J; Zou, Y	1
Herbst, CL; Hur, C; Neugut, AI; Pumpalova, Y; Rogers, AM; Ruff, P; Tan, SX	1
Aoki, H; Araki, H; Arata, T; Katsuda, K; Kimura, Y; Minagi, H; Nagahisa, S; Ogawa, T; Tanakaya, K; Taniguchi, F; Watanabe, M	1
Fukuda, T; Hasegawa, J; Ishiguro, M; Masuda, Y; Nakamura, M; Sakamoto, J; Shibahara, H; Shiroiwa, T; Tomita, N; Yamaguchi, S	1
Fukuda, H; Hamaguchi, T; Ike, H; Ikeda, S; Kanemitsu, Y; Katayama, H; Kobatake, T; Komori, K; Masaki, T; Mizusawa, J; Ohue, M; Ota, M; Sato, T; Shida, D; Shimada, Y; Shiozawa, M; Takiguchi, N; Takii, Y; Tomita, N	1
Cha, Y; Huang, W; Tian, Y; Xiong, H; Yuan, X; Zhang, H	1
Kwakman, JJM; Mol, L; Punt, CJA	1
Bello Crespo, M; Gajete Pablos, MA; Gioseffi, HA; Roa García, DM; Trujillano Ruiz, A	1
Bando, H; Eto, T; Hasegawa, J; Horiuchi, T; Kato, T; Kotaka, M; Manaka, D; Misumi, T; Mizushima, T; Mori, M; Munemoto, Y; Nakamura, F; Nakamura, M; Nishi, M; Ohtsu, A; Oki, E; Sakamoto, J; Sakamoto, Y; Shiozawa, M; Takagane, A; Taniguchi, H; Yamagishi, H; Yoshino, T	1
Brooks, GA; Busam, JA; Daly, AT; Tapp, S; Tosteson, ANA	1
Ahn, JB; Baek, JY; Choi, IS; Han, SW; Hong, YS; Kang, JH; Kang, SY; Kim, HC; Kim, MJ; Kim, SG; Kim, ST; Kim, SY; Kim, TW; Kim, YH; Lee, J; Lee, WY; Lim, SB; Oh, JH; Park, YS; Shin, SJ; Sym, SJ; Yun, SH; Zang, DY	1
Gao, L; Liu, X; Ma, X; Ou, K; Wang, Q; Yang, L; Zhang, H	1
Burgos-Morón, E; Calderón-Montaño, JM; Díaz-Ortega, P; Guillén-Mancina, E; Jiménez-Alonso, JJ; Jiménez-González, V; López-Lázaro, M	1
Chen, R; Li, W; Liang, S; Liu, Z; Wang, C; Wang, J; Zhai, R	1
Aparicio, T; Barbier, E; Bauguion, L; Bouché, O; Cany, L; Carola, E; Cretin, J; Desgrippes, R; Desramé, J; Etienne, PL; Falandry, C; Guérin-Meyer, V; Hiret, S; Hocine, F; Le Brun-Ly, V; Lefevre, LB; Marous, M; Martin, J; Mineur, L; Mosser, L; Reichling, C; Rinaldi, Y; Terrebonne, E; Turpin, A; Turpin, J; Van den Eynde, M	1
Amendt, BA; Cao, H; Chalkley, C; Eliason, S; Hong, L; Liu, Q; Qi, H; Sweat, Y; Xu, H; Zhan, F	1
Begg, W; Kibudde, S	1
Deng, Z; Geng, L; Suo, Q; Wang, J; Wu, N; Yue, Y; Zhang, Q	1
Duan, Z; Giordano, SH; Jones, E; Nguyen, TT; Zhao, H	1
Li, H; Lu, J; Ma, X; Ruan, Y; Wang, L; Wu, X; Xu, H; Xu, X; Zhou, S; Zhou, X	1
Dasari, A; Deming, D; George, TJ; Kopetz, S; Lieu, CH; Lin, Y; Lucas, PC; Sahin, IH; Yothers, G	1
Gil, A; Gil, K; Jurczyk, M; Król, M; Midro, A; Olesiak, W; Stąpor, D	1
Breadner, D; Cheung, WY; Ding, PQ; Gill, S; Gipson, M; Kong, S; Lakkunarajah, S; Loree, JM; Mulder, KE; Spartlin, JL; Welch, SA	1
Amellal, N; André, T; Aubel, P; Campos-Bragagnoli, A; Chmielowska, E; Csöszi, T; Falcone, A; Fougeray, R; Liposits, G; Martín, L; Moiseenko, F; Polo-Marques, E; Saunders, MP; Shparyk, Y	1
de Back, TR; Koopman, M; Mol, L; Nagtegaal, ID; Nijman, L; Punt, CJA; Reinten, RJ; Sommeijer, DW; Ten Hoorn, S; van den Bosch, T; van Dijk, E; van Noesel, CJM; Vermeulen, L; Ylstra, B	1
Cao, P; Chen, X; Leng, W; Meng, W; Qiu, M; Wang, Z; Yu, Y; Zhou, Y	1
Ando, K; Chiku, T; Fukuyama, M; Hashiba, H; Sano, W; Shinoda, K; Suda, K	1
Amano, Y; Furuhata, T; Hisatsune, Y; Katsumata, K; Kikuchi, Y; Kokuba, Y; Naito, M; Negishi, H; Oshima, R; Otsubo, T; Usui, S	1
Dong, Y; Fang, CT; Lin, SH; Meng, JC; Wu, JM; Zhang, A	1
André, T; Bodoky, G; Cremolini, C; Heinemann, V; Maughan, T; McDermott, R; Osterlund, P; Pfeiffer, P; Punt, CJA; Teske, AJ; Van Cutsem, E	1
Aoyama, T; Honda, M; Kanda, M; Kashiwabara, K; Maeda, H; Mayanagi, S; Muto, M; Oba, K; Sakamoto, J; Yoshikawa, T	1
Pamidimukkala, K; Rani Inala, MS	1
Bhatt, K; Herbst, CL; Hur, C; Neugut, AI; Pumpalova, Y; Rogers, AM; Ruff, P; Tan, SX	1
Chin, K; Matsueda, K; Nagaoka, T; Nakayama, I; Ogura, M; Ooki, A; Osumi, H; Shinozaki, E; Takahari, D; Ueno, T; Wakatsuki, T; Yamaguchi, K	1
Ding, K; Dong, C; Fang, X; Hu, H; Li, J; Liao, X; Sun, L; Wang, J; Weng, S; Xiao, Q; Xu, D; Yuan, Y; Zhang, S; Zhong, C	1
Baxter, NN; Brezden-Masley, C; Sue-Chue-Lam, C; Sutradhar, R; Yu, AYX	1
Ahn, DH; Alese, OB; Bekaii-Saab, TS; Draper, A; Griswold, CR; Kang, S; Larson, JJ; Ou, FS; Patel, B; Raman, P; Sonbol, MB; Ueberroth, BE; Walden, DJ; Wu, CS	1
Alanazi, IM; Alzahrani, AR; Arulselvan, P; Azlina, MFN; Falemban, AH; Ibrahim, IAA; Shahid, I; Shahzad, N	1
Fujita, T; Kido, M; Kishi, A; Nakajima, T; Ohno, M; Okazoe, Y; Omiya, S; Suzuki, S	1
Aben, K; Bermejo, I; de Hingh, I; Dekker, A; Geleijnse, G; Lemmens, V; Sieswerda, M; van Erning, F; van Rossum, R; Verbeek, X	1
Bagaloni, I; Barni, S; Bergamo, F; Biondi, E; Bramati, A; Foltran, L; Frontini, L; Galli, F; Graziano, F; Ionta, MT; Labianca, R; Lazzarelli, S; Lonardi, S; Magnani, M; Massidda, B; Mucciarini, C; Nicolini, M; Pella, N; Ricci, V; Ronzoni, M; Rulli, E; Ruzzo, A; Sobrero, A; Sozzi, P; Turci, D; Veltri, E; Verusio, C; Zagonel, V	1
Adena, SKR; Mishra, B; Upadhyay, M; Vardhan, H; Yadav, SK	1
Bando, H; Eto, T; Gamoh, M; Hasegawa, J; Kato, T; Kotaka, M; Maehara, Y; Manaka, D; Mizushima, T; Mori, M; Munemoto, Y; Nakamura, M; Ohtsu, A; Oki, E; Saji, S; Shiozawa, M; Takagane, A; Takeuchi, S; Taniguchi, H; Yamanaka, T; Yoshino, T	1
Li, W; Lin, J; Lu, Z; Pan, Z; Peng, J; Tang, J; Wen, Y; Wu, X; Zhang, R	1
Imamura, CK; Matsumoto, S; Shimizu, A; Yamagiwa, C; Yamazaki, K; Yoshino, T	1
Han, JG; Wang, YB; Wang, ZJ; Wei, GH; Yi, BQ; Zeng, WG; Zhai, ZW; Zhao, BC	1
Fujiwara, A; Hama, N; Hamakawa, T; Hirao, M; Kato, S; Kato, T; Maeda, S; Miyake, M; Miyamoto, A; Miyazaki, M; Nishikawa, K; Sekimoto, M; Takami, K; Uemura, M	1
Anai, H; Kabashima, A; Korehisa, S; Koso, H; Nakamura, Y; Nambara, S; Tahara, K; Umeda, K; Watanabe, K	1
Iveson, T	1
Sun, L; Xu, Y; Yang, Y; Zhang, T	1
Cacho Lavin, D; Calderón, C; Carmona-Bayonas, A; Gomez, D; Jimenez-Fonseca, P; Martinez Cabañez, R; Muñoz, MM	1
Beets-Tan, RGH; Elias, SG; Hong, E; IJzermans, JNM; Jimenez, CR; Koelink, M; Koopman, M; Medema, JP; Roodhart, JML; van de Weerd, S; van den Berg, I; van den Braak, RRJC; van Grevenstein, WMU; van Krieken, JHJM; van Oijen, MGH; van Vliet, D; Vink, GR	1
Bosch, LJW; Coupé, VMH; Elias, S; Fijneman, RJA; Koopman, M; Laclé, MM; Meijer, GA; Phallen, J; Rubio Alarcón, C; Sausen, M; Schraa, SJ; Simmons, J; van den Broek, D; van der Kruijssen, DEW; van Grevenstein, WMU; van Rooijen, KL; Velculescu, VE; Verkooijen, HM; Vink, GR	1
Alberts, SR; Allegra, CJ; Andre, T; Blanke, CD; de Gramont, A; Dixon, JG; Francini, E; George, TJ; Goldberg, RM; Grothey, A; Haller, DG; Kerr, R; Marsoni, S; O'Connell, MJ; Saltz, LB; Seitz, JF; Shi, Q; Taieb, J; Twelves, C; VanCutsem, E; Wagner, AD; Wolmark, N; Yothers, G	1
Choi, GS; Gwang Kim, J; Kang, BW; Kim, HJ; Park, JS; Park, SY; Woo, IT	1
André, T; Aranda, E; Banzi, C; Bloemendal, HJ; Brenner, B; Cervantes, A; Chibaudel, B; de Gramont, A; Dejthevaporn, T; Dewdney, A; Gallego-Plazas, J; Guerin-Meyer, V; Henriques, J; Hoff, PM; Jonker, D; Kim, TW; Martinez-Villacampa, M; Mineur, L; Moehler, M; Rakez, M; Roth, A; Schmoll, HJ; Shim, K; Tabernero, J; Van Cutsem, E	1
Fukunaga, M; Gamoh, M; Kotaka, M; Maehara, Y; Makiyama, A; Manaka, D; Munemoto, Y; Ohtsu, A; Oki, E; Rikiyama, T; Shinkai, H; Shiomi, A; Shiozawa, M; Shitara, K; Sunami, E; Tanida, N; Ueki, T; Yamanaka, T; Yamazaki, K; Yoshino, T	1
Boyne, DJ; Brenner, DR; Cheung, WY; Friedenreich, CM; Hilsden, RJ; Sajobi, TT; Xu, Y; Yusuf, D	1
Aittomäki, K; Andersson, E; Anttonen, AK; Holm, M; Kytölä, S; Osterlund, E; Osterlund, P; Ovissi, A; Ristimäki, A; Soveri, LM	1
André, T; Boukovinas, I; Georgoulias, V; Grothey, A; Harkin, A; Iveson, T; Labianca, R; Meyerhardt, J; Meyers, J; Niedzwiecki, D; Oki, E; Saunders, M; Shi, Q; Shields, A; Sobrero, A; Souglakos, I; Taieb, J; Torri, V; Vernerey, D; Yamanaka, T; Yoshino, T	1
André, T; Cohen, R; Garcia-Larnicol, ML; Neuzillet, C; Ouali, K; Rousseau, B; Samalin, E; Taieb, J; Tournigand, C; Turpin, A	1
Chen, H; Lu, Y; Xu, C; Xu, L; Yao, Q; Yao, W; Zhang, L; Zhang, R; Zhang, X	1
Aiba, T; Ando, M; Ando, Y; Fujiwara, M; Hashimoto, R; Hattori, N; Hayashi, M; Hayashi, N; Ishigure, K; Ishiyama, A; Kanda, M; Kinoshita, T; Kobayashi, D; Kodera, Y; Koike, M; Muro, K; Murotani, K; Nakamura, M; Nakayama, G; Sakai, M; Sato, Y; Sonohara, F; Takano, N; Tanaka, C; Taniguchi, H; Teramoto, H; Uehara, K; Umeda, S; Yamada, S; Yokoyama, H	1
Goseki, N; Koike, M; Kuwabara, H; Morimoto, K; Nakamura, N; Ryu, K; Sanada, T; Sato, T	1
Chen, W; Dong, S; Lei, S; Liu, X; Wang, G; Xu, S; Yan, J; Zhuo, S	1
Cai, PQ; Chang, H; Chen, BQ; Gao, YH; Li, LR; Liu, Q; Wang, QX; Wu, XJ; Xiao, WW; Xie, WH; Yuan, Y; Zeng, ZF; Zhang, R; Zhou, WH	1
Amoroso, D; Banzi, M; Bidoli, P; Bilancia, D; Bochicchio, AM; Bozzarelli, S; Carlomagno, C; Ciuffreda, L; Corsi, D; De Stefano, A; Di Bartolomeo, M; Ferrari, D; Frassineti, L; Galli, F; Garattini, SK; Labianca, R; Lonardi, S; Mambrini, A; Montesarchio, V; Pasini, F; Pastorino, A; Pusceddu, V; Ronzoni, M; Rosati, G; Zampino, MG; Zaniboni, A	1
Aleshin, A; Billings, PR; Ebi, H; Kato, T; Kotani, D; Mishima, S; Mori, M; Nakamura, Y; Oki, E; Rabinowitz, M; Sawada, K; Shirasu, H; Takemasa, I; Taniguchi, H; Yamanaka, T; Yoshino, T; Yukami, H	1
Anger, F; Germer, CT; Kelm, M; Klein, I; Kunzmann, V; Löb, S; Schlegel, N; Schollbach, J; Wiegering, A	1
Chu, E; Frohlich, MM; Wang, X	1
Aiken, C; Blinman, P; Boadle, D; Goldstein, D; Harkin, A; Haydon, A; Iveson, T; Jefford, M; Martin, A; Morris, M; Segelov, E; Stockler, MR; Tebbutt, N	1
Hanna, C; Iveson, P; Iveson, T; Levasseur, A; Meyerhardt, J; Zhang, S	1
An, MS; Baik, H; Kang, SH; Kim, KH; Lee, HS; Lee, SH; Oh, MK; Park, J; Seo, SH	1
Chen, J; Chen, W; Dong, H; Wang, G; Wang, W	1
Abe, T; Furuhashi, T; Fuyuno, S; Hatada, T; Sato, N	1
Farajnia, S; Fazeli, M; Hamidian, G; Namvaran, A; Rezazadeh, H	1
Abadi, S; Gill, S; Sha, A	1
Fang, W; Fu, Y; Wei, J	1
Delaney, TA; O'Sullivan, N; Yap, FHX	1
Hansen, TF; Jakobsen, A; Jensen, LH; Kjær-Frifeldt, S; Lindebjerg, J; Rafaelsen, SR; Sørensen, FB	1
Azrumelashvili, T; Chikovani, T; Janikashvili, N; Kikodze, N; Mizandari, M; Paksashvili, N; Pantsulaia, I; Shanava, K	1
Nunes, AA; Pereira, LRL; Peria, FM; Ungari, AQ	1
Araújo, F; Baptista, MJ; Casa-Nova, M; Godinho, J; Mesquita, T; Passos Coelho, JL; Vale, J	1
Barboza-Quintana, O; Buenaventura-Cisneros, S; Camacho-Morales, A; Castro-Rojas, CA; Esparza-Mota, AR; Garcia-Gonzalez, IS; Gonzalez-Guerrero, JF; Hernandez-Cabrera, F; Maldonado-Garza, H; Ortiz-Lopez, R; Rojas-Martinez, A; Romero-Diaz, VJ; Sanchez-Lopez, JY	1
Kagawa, Y; Kato, T; Katsura, Y; Kawai, K; Murakami, K; Murata, K; Naito, A; Nakatsuka, S; Nose, Y; Omura, Y; Sakamoto, T; Takase, K; Takeda, Y; Takeno, A; Tamura, S	1
Akioka, K; Ioka, E; Ishikawa, T; Kadotani, Y; Nakano, K; Okugawa, K; Osaka, M; Osaka, Y; Takemoto, M; Tsuchiya, K	1
Huijbers, A; Johnstone, EC; Kerr, DJ; Kerr, RS; Mesker, WE; Tollenaar, RAEM; van Pelt, GW	1
Ishibashi, K; Ishida, H; Kato, H; Kato, R; Koda, K; Kosugi, C; Mori, M; Narushima, K; Oya, M; Shuto, K; Tanaka, S; Yoshimatsu, K	1
Abadi, S; Cheung, WY; Gill, S; Ho, MY; Kennecke, HF; Loree, JM; Mulder, KE; Sha, A; Soleimani, M; Spratlin, JL	1
Akiyoshi, T; Fujimoto, Y; Fukunaga, Y; Kawakami, K; Konishi, T; Matsusaka, S; Nagayama, S; Shinozaki, E; Suenaga, M; Sugisaki, T; Ueno, M; Yamaguchi, T; Yokokawa, T	1
Dudhipala, N; Puchchakayala, G	1
Cao, S; Hua, D; Jiang, Y; Kong, J; Mao, Y; Meng, F; Wang, C; Wang, W	1
Anan, C; Katada, E; Mitsui, A; Sasaki, S; Uematsu, N	1
Andre, T; Boukovinas, I; Grothey, A; Iveson, T; Kerr, R; Labianca, R; Meyerhardt, JA; Meyers, JP; Niedzwiecki, D; Paul, J; Renfro, LA; Sargent, DJ; Saunders, M; Shi, Q; Shields, AF; Sobrero, AF; Souglakos, J; Taieb, J; Torri, V; Vernerey, D; Watanabe, T; Yamanaka, T; Yoshino, T	1
Chadda, RK; Deb, KS; Garg, H; Prakash, S	1
Banzi, M; Barni, S; Cantore, M; Ciuffreda, L; Di Bartolomeo, M; Ferrari, D; Labianca, R; Lonardi, S; Maiello, E; Marchetti, P; Pasini, F; Pella, N; Rimassa, L; Ronzoni, M; Rosati, G; Rulli, E; Scartozzi, M; Sobrero, A; Zagonel, V; Zampino, MG; Zaniboni, A	1
Baretti, M; Bozzarelli, S; Giordano, L; Personeni, N; Pressiani, T; Rimassa, L; Santoro, A; Tronconi, MC	1
Endo, M; Ikenaga, S; Iwama, M; Jin, H; Kusumi, T; Ohashi, M; Yokoyama, M	1
Aderka, D; Boursi, B; Giantonio, B; Golan, T; Halpern, N; Mamtani, R; Margalit, O; Reiss, KA; Shacham-Shmueli, E; Yang, YX	1
Christiansen, AB; Larsen, FO; Nelausen, KM; Nielsen, DL; Rishøj, A	1
Gelderblom, HJ; Mancao, C; Mesker, WE; Putter, H; Tollenaar, RA; van Pelt, GW; Zunder, SM	1
Ganesh, M; Jang, HT; Rathnam, G; Sinha, P; Udhumansha, U	1
Aghmesheh, M; Brungs, D; Carolan, M; Clingan, P; de Souza, P; Ranson, M; Rose, J	1
Formica, V; Loupakis, F; Roselli, M; Zaniboni, A	1
Chu, E; Lee, JJ	1
Esna-Ashari, O; Fathi-Azarbayjani, A; Kheradmand, F; Malekinejad, H; Mohammadian, M; Rasmi, Y; Zeynali-Moghaddam, S	1
Arita, S; Koike, N; Oshima, Y; Takeuchi, T; Watanabe, H	1
Taieb, J; Zaanan, A	1
Cho, S; Jeong, SY; Kim, MJ; Kwon, YH; Lee, KY; Park, JW; Park, KJ; Ryoo, SB	1
Amagasa, H; Ami, K; Ando, M; Fukuda, A; Ganno, H; Imai, K; Kajiyama, D; Kawaguchi, M; Matsui, S; Noguchi, T; Ohira, K; Sugita, H	1
Furutani, A; Hariu, T; Kitade, T; Nako, Y; Sonoyama, T; Wakasa, M; Yamasaki, S	1
Jiang, H; Liu, J; Wang, Y; Xu, N; Yu, X	1
Ishibashi, K; Ishida, H; Kato, H; Kobayashi, M; Koda, K; Maekawa, H; Matsunami, T; Nakajima, H; Oda, N; Ooki, S; Oshiro, M; Oya, M; Tanakaya, K; Tsubaki, M; Yamada, T; Yokomizo, H; Yokoyama, M; Yoshimatsu, K	1
Degirmencioglu, S; Demiray, AG; Dogu, GG; Senol, H; Tanrıverdi, O; Yaren, A	1
Boyne, DJ; Brenner, DR; Cheung, WY; Cuthbert, CA; Friedenreich, CM; Hilsden, RJ; O'Sullivan, DE; Sajobi, TT	1
Ciardiello, D; Ciardiello, F; Conzo, G; Coppola, N; De Falco, V; De Vita, F; Giunta, EF; Marinaccio, A; Martinelli, E; Napolitano, S; Natalicchio, MI; Troiani, T; Vietri, MT; Vitale, P; Vitiello, PP; Zanaletti, N	1
Kaiho, T; Kataoka, M; Kobayashi, S; Machida, T; Nakadai, E; Nishimura, M; Oka, Y; Okaniwa, A; Suda, R; Yamada, H; Yanagisawa, S	1
Coley, H; Kadakia, KC; Salem, ME; Worrilow, WM	1
Anagnosopoulos, A; Androulakis, N; Ardavanis, A; Athanasiadis, A; Athanasiadis, E; Bompolaki, I; Boukovinas, I; Christofyllakis, C; Christopoulou, A; Emmanouilides, C; Georgoulias, V; Kakolyris, S; Kalisperi, A; Karampeazis, A; Katopodi, U; Kentepozidis, N; Kourousis, C; Makrantonakis, P; Mavroudis, D; Papadopoulos, G; Prinarakis, E; Souglakos, J; Vaslamatzis, M; Xynogalos, S; Ziras, N	1
Deng, HX; Li, Q; Wei, YQ; Wen, F; Xie, Q	1
Deguchi, T; Fukui, A; Iwase, K; Kawata, J; Matsuda, C; Nezu, R; Nishikawa, K; Takagi, M; Tamagawa, H; Tanaka, Y	1
Benson, AB	1
Albini, A; Banzi, M; Boni, C; Casali, B; Farnetti, E; Focaccetti, C; Magnani, E; Nicoli, D; Savoldi, L	1
Hashimoto, T; Kimura, S; Toyono, M; Usuba, O; Yokoyama, M	1
Fujiyama, Y; Kaneko, H; Kikuchi, M; Kinoshita, S; Nishizawa, T; Sakuno, T; Suzuki, H; Takahashi, M	1
Aglietta, M; Artale, S; Cagnazzo, C; Capussotti, L; Cascinu, S; De Carlis, L; Di Fabio, F; Fornarini, G; Gioeni, L; Leone, F; Marino, D; Pinto, C; Pugliese, R; Sartore-Bianchi, A; Siena, S; Tampellini, M	1
Badzek, S; Bilic, E; Golem, H; Gorsic, I; Kekez, D; Librenjak, N; Miletic, V; Plestina, S; Prejac, J	1
Arnold, D; Beretta, GD; Cervantes, A; Labianca, R; Mandalà, M; Mosconi, S; Nordlinger, B	1
Hasegawa, H; Kubo, H; Miyahara, M; Nakasuga, C; Tada, K	1
Ikeda, H; Kato, H; Kodera, M; Mizuno, K; Oishi, M; Seshimo, K; Toshima, T; Yamamura, M; Yamashita, Y	1
Chen, Y; Cui, YH; Guo, X; Liu, TS; Yu, YY; Zhou, YH; Zhuang, RY	1
Asaka, S; Katsube, T; Kohno, T; Miyaki, A; Miyazawa, M; Murayama, M; Naritaka, Y; Shimakawa, T; Shimazaki, A; Shiozawa, S; Usuda, A; Yamaguchi, K; Yokomizo, H; Yoshimatsu, K	1
Ghosh, S; Loree, JM; Mulder, KE; Spratlin, JL	2
Koshida, Y; Mukai, K; Nishi, T; Shimoyama, Y; Toriumi, F; Yamamoto, T; Yamanashi, T	1
Guo, XD; Hu, DL; Sun, ZN; Zhao, YM	1
de Haes, JH; Henselmans, I; van Laarhoven, HW	1
Cai, Q; Chen, X; Ji, J; Jiang, J; Liu, B; Shi, H; Shi, M; Yu, Y; Zhang, J; Zhu, Z	1
Gervasi, E; Giovanardi, F; Pezzuolo, D; Prati, G; Scaltriti, L; Scarabelli, L	1
Hara, K; Ishii, T; Kondo, H; Koyama, I; Morita, Y; Suzuki, A; Tashiro, J; Yamaguchi, S	1
Bekaii-Saab, T; Benson, AB; Chan, E; Chen, YJ; Cooper, HS; Engstrom, PF; Enzinger, PC; Fenton, MJ; Freedman-Cass, DA; Fuchs, CS; Gregory, KM; Grem, JL; Hunt, S; Kamel, A; Leong, LA; Lin, E; Messersmith, W; Mulcahy, MF; Murphy, JD; Nurkin, S; Rohren, E; Ryan, DP; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Venook, AP; Willett, CG	1
Battisti, S; Guida, FM; Pagliara, E; Santini, D; Tonini, G; Zobel, BB	1
Armstrong, DE; Ghosh, S; Kim, CA; Mulder, KE; Spratlin, JL	1
Ahn, JB; Bello, M; Charoentum, C; Chen, LT; Cheng, AL; Ciardiello, F; de Lima Lopes, G; Ho, GF; Kim, TW; Köhne, CH; Kong, HL; Lam, KO; Li, J; Liu, TS; Ma, BB; Park, YS; Shaw, M; Sriuranpong, V; Sudoyo, AW; Teh, C; Vaid, AK; Wang, JY; Zhang, J; Zhang, SZ	1
Cleator, S; Dzaye, O; Nihoyannopoulos, P	1
Kawara, H; Mitani, T; Noguchi, Y; Shimizu, Y; Tokuyama, Y; Tsurushima, M; Uchiyama, K	1
Chiche, L; Dicostanzo, MP; Fongue, J; Harlé, JR; Lardet, D; Meunier, B; Richard, MA; Rouby, F; Terrier, JP	1
Chaikledkaew, U; Chindavijak, S; Khuhaprema, T; Lausoontornsiri, W; Lerdkiattikorn, P; Tantai, N; Teerawattananon, Y	1
Ban, T; Ikegaya, Y; Isogai, N; Kawachi, J; Miyake, K; Ogino, H; Shimoyama, R; Watanabe, K	1
Faez, L; Garrido, M; Jiménez-Fonseca, P; Menendez, MD; Rodriguez, D; Ruiz, AL; Sanchez Lorenzo, ML; Solis, MP; Uriol, E; Viéitez, JM	1
Cartwright, T; Haller, D; Lee, S; McKenna, E; O'Connell, MJ; Saif, M; Schmoll, HJ; Sun, W; Twelves, C; Yothers, G	1
Du, ZD; He, XF; Li, Q; Tang, RL; Wen, F; Yao, K; Zhang, PF	1
Aksoy, A; Arpaci, E; Bahceci, A; Bayoglu, IV; Besiroglu, M; Dane, F; Duran, AO; Hacibekiroglu, I; Inanc, M; Karaca, H; Menekse, S; Ozkan, M; Sevinc, A; Tanriverdi, O; Uysal, M; Yapici, HS; Yazilitas, D	1
Fennig, S; Greenberg, G; Leshem, Y; Talianski, E; Wolf, I	1
Desurmont, T; Duchene, B; Duhamel, A; Gosset, P; Hebbar, M; Huet, G; Jonckheere, N; Leteurtre, E; Millet, G; Pruvot, FR; Ramdane, N; Skrypek, N; Truant, S; Van Seuningen, I	1
Kakizawa, N; Kato, T; Noda, H; Rikiyama, T; Toyama, N; Watanabe, F	1
Guggenberger, D; Hansen, R; Jacobs, G; Kröning, H; Schardt, C; Schmidt, P; Steffens, CC; Tschechne, B; Valdix, AR; Wohlfarth, T	1
Hosaka, S; Kawamoto, S; Maeno, H; Ohara, C; Okubo, S; Umemoto, S; Yonemitsu, K; Yoshida, T	1
Ishizu, H; Kuji, M; Masuko, H; Matsumoto, S; Takahashi, M; Takahashi, S; Tanioka, T; Yamagami, H	1
Hanyu, T; Hashimoto, Y; Hosoi, M; Ishikawa, T; Kameyama, H; Kobayashi, T; Kosugi, S; Koyama, Y; Minagawa, M; Nakano, M; Nogami, H; Sakata, J; Shimada, Y; Takizawa, K; Wakai, T	1
Doi, S; Kan, K; Maruyama, H; Murata, K; Nakaguchi, K; Nakano, K; Nushijima, Y; Okamura, S; Sugimoto, K	1
Hanyu, T; Ichikawa, H; Ishikawa, T; Kameyama, H; Kobayashi, T; Kosugi, S; Koyama, Y; Minagawa, M; Nakano, M; Sakata, J; Shimada, Y; Tanaka, R; Wakai, T	1
Ishii, K; Kanamoto, A; Miyanaga, S; Noto, M; Takeda, T; Tani, T; Yagi, M	1
Hassan, AS; Naicker, M; Wan Ishak, WZ; Yusof, KH	1
Adams, VR; Flannery, AH; Kido, K; Morehead, RS	1
Akai, F; Hirasawa, N; Hiratsuka, M; Hishinuma, E; Hosono, H; Mori, T; Yamashita, H	1
Andersen, F; Fischer, A; Jakobsen, A; Jensen, LH; Jørgensen, JC; Larsen, O; Lindebjerg, J; Pløen, J; Rafaelsen, SR; Vilandt, J	1
Dam, C; Jakobsen, A; Lund-Rasmussen, V; Pløen, J; Rafaelsen, SR	1
de Braud, F; Haller, DG; Hill, M; Hoersch, S; Maroun, J; Price, T; Rittweger, K; Schmoll, HJ; Tabernero, J; Van Cutsem, E	1
Alés-Díaz, I; Benavides-Orgaz, M; Bermejo-Pérez, MJ; Durán-Ogalla, G; Galeote-Miguel, AM; Rodelo-Haad, LE	1
Hayakawa, M; Koketsu, H; Matsuda, S; Nagata, N	1
Busakhala, N; Chite, F; Kigen, G; Loehrer, P; Njiru, E	1
Chang, AY; Cheung, WY; Ho, MY; Ruan, JY	1
Kim, BS; Kim, GW; Kim, HS; Kim, JM; Kim, MB; Kim, WI; Ko, HC; Mun, JH; Song, M	1
Cai, S; Hu, J; Xu, Y	1
Handa, N; Minakata, K; Osawa, H	1
Maroñas-Jiménez, L; Mascaró, JM; Pau-Charles, I; Pigem, R	1
Achrekar, MS; Carvalho, MD; D'souza, A; Govindarajan, S; Gupta, S; Murugan, K; Ostwal, V	1
Avallone, A; Capozzi, M; Capuozzo, M; Casaretti, R; Cassata, A; De Divitiis, C; Iaffaioli, VR; Maiolino, P; Nappi, A; Nasti, G; Ottaiano, A; Quagliariello, V; Romano, C; Scala, S; Silvestro, L; Tafuto, S	1
André, T; Aparicio, T; Bedenne, L; Carola, E; Cristol-Dalstein, L; Faroux, R; Francois, E; Maillard, E; Paillaud, E; Retornaz, F; Seitz, JF	1
Sugihara, K; Tsuji, Y	1
Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K	1
Baudot, A; Bosacki, C; Bourmaud, A; Chauvin, F; Collard, O; Jacquin, JP; Moine, V; Moriceau, G; Muron, T; Oriol, M; Pacaut, C; Regnier-Denois, V; Saban-Roche, L; Tinquaut, F	1
de Ridder, JAM; de Wilt, JH; Koopman, M; Mekenkamp, LJ; Punt, CJA; van der Stok, EP; Verhoef, C; Wiering, B	1
Buyukozturk, S; Colakoglu, B; Demir, S; Gelincik, A; Olgac, M; Saglam, S	1
Abe, T; Akizawa, H; Kobashi, N; Kuge, Y; Matsumoto, H; Meike, S; Nishijima, K; Ohkura, K; Okumura, Y; Tamaki, N; Zhao, S	1
Creemers, GJ; Janssen-Heijnen, ML; Lemmens, VE; Maas, HA; Pruijt, JF; Razenberg, LG; van Erning, FN	1
Amlani, A; Cheung, WY; Kumar, A; Ruan, JY	1
Kubicka, S	1
A-Cienfuegos, J; Arredondo, J; Baixauli, J; Chopitea, A; González, I; Hernández-Lizoain, JL; Martínez, P; Pastor, C; Rodriguez, J; Sola, JJ	1
Aprile, G; Banzi, M; Barni, S; Cantore, M; Ciuffreda, L; Di Bartolomeo, M; Ferrari, D; Labianca, R; Lonardi, S; Maiello, E; Marchetti, P; Massida, B; Pasini, F; Rimassa, L; Ronzoni, M; Rosati, G; Rulli, E; Scartozzi, M; Sobrero, A; Zagonel, V; Zampino, MG; Zaniboni, A	1
Beijers, TAJM; Janssen-Heijnen, MLG; Lemmens, VEPP; Slooter, GD; van de Poll-Franse, LV; van Erning, FN; Vreugenhil, A; Wegdam, JA; Wijsman, JH	1
Akase, T; Arakawa, I; Inoue, T; Iyoda, T; Kanno, H; Nagase, S; Uetsuka, Y	1
Ihemelandu, C; Sugarbaker, PH	1
Ljubojevic Hadzavdic, S; Murtezani, I; Skerlev, M; Stulhofer Buzina, D	1
Hamada, C; Hazama, S; Ike, H; Ishida, H; Ishiguro, M; Kondo, K; Kunieda, K; Maeda, K; Masuko, H; Mishima, H; Morita, T; Nishimura, G; Okajima, M; Sadahiro, S; Saji, S; Sakamoto, J; Sasaki, K; Sugihara, K; Suto, T; Tomita, N	1
Akagi, Y; Baba, H; Emi, Y; Kakeji, Y; Maehara, Y; Minami, K; Morita, M; Nagata, S; Natsugoe, S; Ohgaki, K; Okamoto, M; Oki, E; Okumura, H; Suenaga, T; Tanaka, E; Tanaka, T; Tokunaga, S; Touyama, T	1
Fukabori, M; Itoh, Y; Morita, A; Nakayama, M; Saito, H; Suematsu, Y; Takahashi, M; Wakabayashi, K; Yamagishi, S	1
Fujii, T; Funahashi, K; Kaneko, H; Kaneko, T; Katayanagi, T; Koda, T; Koike, J; Kurihara, A; Masuhara, H; Sawaguchi, Y; Shimada, H; Shiokawa, H; Suzuki, T; Ushigome, M; Watanabe, Y	1
Komatu, T; Nomura, S; Ogasawara, T; Sato, Y; Shida, T; Takahara, Y; Takahashi, M; Uno, H	1
Hashimoto, Y; Hotta, S; Iwaki, T; Kameyama, H; Kobayashi, T; Oyamatsu, M; Sakata, J; Sato, K; Sato, Y; Shimada, Y; Wakai, T	1
Hoshino, H; Kawada, J; Kim, Y; Nishino, M; Okano, M; Okuyama, M; Tsujinaka, T	1
Doki, Y; Haraguchi, N; Hata, T; Matsuda, C; Mizushima, T; Mori, M; Nishimura, J; Nishizawa, Y; Takahashi, H; Yamamoto, H	1
Hara, K; Ishii, T; Kondo, H; Shimizu, H; Suzuki, A; Takemoto, K; Tashiro, J; Yamaguchi, S	1
Duhoux, F; Mano, MS	1
Cheng, RC; Diao, C; Liu, QY; Su, YJ; Wei, XP; Xu, JB; Zhang, JM	1
Barberis, G; Cannone, M; Comella, P; Condemi, G; Farris, A; Filippelli, G; Maiorino, L; Massidda, B; Natale, D; Palmeri, S	1
Amadori, D; Antonuzzo, L; Barone, C; Bertetto, O; Carlo Merlano, M; Di Costanzo, F; Gasperoni, S; Labianca, R; Longo, F; Luppi, G; Mansueto, G; Ravasio, R; Sobrero, A; Vinante, O	1
Arnold, D; Bovenschulte, H; Coutelle, O; Fries, JW; Hacker, U; Stippel, D; Weihrauch, MR	1
Huh, JW; Jung, EJ; Kwon, JE; Lee, KY; Park, YA; Sohn, SK	1
Arnold, D	1
Gennatas, C; Gennatas, S; Michalaki, V	1
Gibson, OJ; Larsen, ME; Pearson, S; Rowntree, J; Smith, J; Tarassenko, L; Weaver, A; Young, AM	1
Ledbetter, L; Saif, MW; The, A	1
Akyürek, N; Benekli, M; Büyükberber, S; Coşkun, U; Demirci, U; Oztürk, B; Tonyali, O; Yildiz, R; Yilmaz, G	1
Murphy, KC	1
Easaw, JC; Vickers, MM	1
Bozkurt, MT; Cirak, Y; Degirmenci, M; Demir Piskin, G; Durusoy, R; Gorumlu, G; Karabulut, B; Karaca, B; Sanli, UA; Tunali, D; Uslu, R	1
Gunderson, HD; Leung, N; Shaikh, A; Wiisanen, ME	1
Achilli, F; Farina, A; Malafronte, C; Valsecchi, MA	1
Saltz, LB; Segal, NH	1
Ansaloni, L; Bazzoli, F; Cennamo, V; Ceroni, L; Eusebi, LH; Fuccio, L; Laterza, L; Martoni, AA; Minardi, ME; Mutri, V; Pinna, AD; Salfi, N	1
Fukuda, T; Ohashi, Y; Shimozuma, K; Shiroiwa, T; Tsutani, K	1
Quinn, B; Salvage, AV	1
Cho, YB; Chun, HK; Kim, HC; Lee, WY; Yun, HR; Yun, SH	1
Ding, PR; Li, LR; Lin, JZ; Pan, ZZ; Peng, ZH; Wan, DS; Wu, XJ; Zhou, ZG	1
An, X; Feng, F; He, YJ; Jiang, WQ; Li, YH; Wang, FH; Wang, ZQ; Xiang, XJ; Xu, RH	1
Kakar, M; Olsen, DR; Røe, K; Seierstad, T	1
Angus, E; Fincher, S; Garg, R	1
Lee, C; Saunders, M	1
Uña, E	1
Chun, HK; Lee, WS; Lee, WY; Son, HS; Yun, SH	1
Bae, SH; Chae, YS; Choi, GS; Jun, SH; Kang, BW; Kim, JG; Kim, NS; Moon, JH; Park, JH; Park, JY; Ryoo, HM; Sohn, SK	1
Arai, T; Hirai, H; Imagaki, K; Iwasawa, Y; Kobayashi, M; Kotani, H; Mizuarai, S; Nishibata, T; Ohtani, J; Okada, M; Sakai, N; Sakai, T; Yoshizumi, T	1
Meirovitz, A; Sonnenblick, A	1
Block, S	1
Arnold, D; Bruch, HP; Kirchner, T; Kubicka, S; Reinacher-Schick, A; Ridwelski, K; Schmoll, HJ; Trarbach, T	1
Adenis, A; Bennouna, J; Bergougnoux, L; Conroy, T; Douillard, JY; Ducreux, M; Faroux, R; Hebbar, M; Kockler, L; Lledo, G; Rebischung, C; Ychou, M	1
Chauvin, F; Guastalla, JP; Jacquin, JP; Nourissat, A; Poirson, J; Regnier Denois, V	1
Xu, JM	1
Aarntzen, EA; Adema, GJ; de Boer, A; de Vries, IJ; Figdor, CG; Lesterhuis, WJ; Preijers, FW; Punt, CJ; Scharenborg, NM; van de Rakt, M; van Spronsen, DJ	1
Awada, A; Besse-Hammer, T; Brendel, E; Delesen, H; Gil, T; Hendlisz, A; Joosten, MC; Lathia, CD; Loembé, BA; Piccart-Ghebart, M; Van Hamme, J; Whenham, N	1
Zhang, SZ	1
Black, JM; Boh, EE; Farris, PK; Hodari, KT; Lewis, AT; Rogers, N	1
Czaykowski, P; Gordon, VL; Harding, GA	1
de Braud, F; Gilberg, F; Haller, DG; Hill, M; Maroun, J; Price, T; Rittweger, K; Schmoll, HJ; Tabernero, J; Van Cutsem, E	1
Arima, N; Shigaki, N; Sugita, H; Suzuki, S; Yamashita, H; Yokoyama, S	1
Gilbar, P; Sorour, N	1
Bang, SM; Chang, HJ; Kang, SB; Kim, DW; Kim, JH; Kim, YJ; Lee, JS; Lee, KW	1
Al-Niaimi, F; Lyon, C	1
Cassidy, J; Díaz-Rubio, E; Gilberg, F; McKendrick, J; Scheithauer, W; Seitz, JF; Twelves, C; Van Hazel, G; Wong, A	1
Goto, H; Hara, K; Higuchi, K; Hijioka, S; Kawai, H; Kondo, S; Mizuno, N; Nakamura, M; Niwa, Y; Ogura, T; Sawaki, A; Tajika, M; Yamao, K	1
Aparicio, J; Díaz-Rubio, E; Feliu, J; García-Carbonero, R; González-Flores, E; Grande, E; Pérez-Hoyos, T; Salud, A; Torres, E; Valero, M; Valladares-Ayerbes, M; Vieitez, JM	1
Koopman, M; Mol, L; Punt, CJ; Redekop, WK; Uyl-de Groot, CA; van Gils, CW	1
Akagi, Y; Ando, K; Emi, Y; Kakeji, Y; Kitazono, M; Maehara, Y; Morita, M; Natsugoe, S; Ogata, Y; Oki, E; Saeki, H; Sakaguchi, Y; Samura, H; Shirouzu, K; Sirzen, F; Tokunaga, S	1
Agharbi, FZ; Benhemmne, H; Daoudi, K; Elmesbahi, O; Mernissi, FZ; Meziane, M; Mikou, O	1
Fukuda, M; Hanada, K; Hata, H; Ikai, I; Kubo, K; Moriyama, S; Murakami, T; Ogiso, S; Okazaki, S; Okuchi, Y; Otani, T; Sakata, S; Setoguchi, Y; Tanaka, M; Tani, M; Une, Y; Yamaguchi, T; Yamato, T; Yasui, H	1
Imai, E; Ito, I; Ito, Y; Kosugi, T; Maruyama, S; Matsuo, S; Mizuno, M; Ozaki, T; Sato, W; Suzuki, Y; Tsuboi, N; Yasuda, K; Yasuda, Y	1
Cao, F; Han, N; He, K; Jin, K; Lan, H; Li, G; Teng, L; Xie, B; Xu, Z	1
Dokmanovic, L; Janic, D; Krstovski, N; Lazic, J; Paripovic, L; Rodic, P	1
Bai, W; He, AR; Hwang, J; Marshall, J; Mikhail, S; Navarro, R; Pishvaian, M; Shivapurkar, N; Wellstein, A	1
Stiefelhagen, P	1
Chachad, S; Malhotra, G; Naidu, R; Purandare, S	1
Benekli, M; Berk, V; Buyukberber, S; Cetin, B; Coskun, U; Isikdogan, A; Kaplan, MA; Ozkan, M; Tufan, G	1
André, T; Bajetta, E; Bodoky, G; Cartwright, TH; Clarke, S; Cunningham, D; de Gramont, A; Hecht, JR; Hoff, PM; Im, SA; Maindrault-Goebel, F; Makrutzki, M; Moore, MJ; Rivera, F; Salazar, R; Schmoll, HJ; Shacham-Shmueli, E; Shang, A; Tabernero, J; Van Cutsem, E	1
Schmutz, JL; Trechot, P	1
Chan, AO; Chan, HY; Ng, CM; Shek, CC; Tiu, SC	1
Chung, K; Hanada, S; Iwata, T; Kato, T; Miura, T; Nakata, K; Toda, M	1
Akiyoshi, T; Arita, J; Fujimoto, Y; Fukunaga, Y; Ikeda, A; Koga, R; Konishi, T; Mizunuma, N; Mukai, T; Nagasue, Y; Nagayama, S; Oikawa, Y; Saiura, A; Shinozaki, E; Suenaga, M; Ueno, M; Yamaguchi, T; Yamakawa, K; Yamamoto, C	1
Amamori, K; Shigematsu, T; Shirai, M; Sunda, K; Takeda, K; Yamagiwa, K; Yamanda, T	1
Alexander, GC; de Souza, JA; Meropol, NJ; Newcomer, LN; Perkins, M; Polite, B; Ratain, MJ	1
Arredondo, J; Baixauli, J; Chopitea, A; González, I; Hernández-Lizoáin, JL; Pastor, C; Rodríguez, J; Vigil, C	1
Mayor, S	1
Brickell, K; Porter, D; Thompson, P	1
Maeda, Y; Sasaki, E; Sasaki, T	1
Begbie, S; Borner, M; Burns, WI; Burris, HA; Cassidy, J; Garcia-Alfonso, P; Jodrell, D; Koralewski, P; Levine, EL; Maroun, J; Marschner, N; McKendrick, J; Scheithauer, W; Tujakowski, J; Twelves, C; Van Hazel, G; Wong, A; Zaluski, J	1
Kondo, Y; Sato, A; Taguchi, T; Terashima, M	1
Bajetta, E; Biasco, G; Brandi, G; Calabrese, C; Di Battista, M; Pantaleo, MA; Poggi, R	1
Grem, JL; Leonard, GD; Quinn, MG; Wagner, MR	1
Reddy, GK	1
Fujimura, T; Fushida, S; Miwa, K; Morita, A; Nagai, N; Ninomiya, I; Nishimura, G; Ohta, T; Takino, T; Terada, I; Yoshizumi, T	1
Grothey, A; Marsé, H; Valverde, S; Van Cutsem, E	1
Aksu, G; Fayda, M; Kapran, Y; Sakar, B	1
Cao, S; Durrani, FA; Rustum, YM	1
Bocci, G; Danesi, R; Di Paolo, A	1
Aksoy, S; Dinçer, M; Karaca, B; Yalçin, S	1
Vega-Stromberg, T	1
Di Costanzo, F; Doni, L	1
Abt, M; Burris, H; Carrato, A; Cassidy, J; Cervantes, A; Fagerberg, J; Georgoulias, V; Husseini, F; Jodrell, D; Koralewski, P; Kröning, H; Maroun, J; Marschner, N; McKendrick, J; Nowacki, MP; Pawlicki, M; Rosso, R; Scheithauer, W; Schüller, J; Seitz, JF; Stabuc, B; Tujakowski, J; Twelves, C; Van Hazel, G; Wong, A; Zaluski, J	1
Allegra, C; Sargent, DJ	1
Janney, LM; Waterbury, NV	1
Cassidy, J; Filipovic-Ljeskovic, I; Jelic, S; Nikolic-Tomasevic, Z; Tomasevic, Z	1
Ahn, JS; Chang, HM; Kang, WK; Kang, YK; Kim, HK; Kim, SR; Kim, TW; Lee, KH; Park, JO; Ryoo, BY; Zang, DY	1
Almerud, A; Gubanski, M; Lideståhl, A; Lind, PA; Naucler, G	1
Glasmacher, A; Lamberti, C; Sauerbruch, T	1
Ershler, WB	1
Tuma, RS	1
Beham, A; Bertetto, O; Bustová, I; Cassidy, J; Cowell, W; Coxon, F; Díaz-Rubio, E; Douillard, JY; Dufour, P; Figer, A; Fountzilas, G; Garrison, LP; Jelic, S; Johnston, PG; Lesniewski-Kmak, K; Malzyner, A; Maughan, TS; McKendrick, JJ; Patel, KK; Scheithauer, W; Twelves, C	1
McAlister, H; Thompson, PI; Wijesinghe, N	1
Arai, Y; Doi, T; Hatake, K; Hyodo, I; Mishima, H; Nakagawa, K; Shirao, K; Takemiya, S; Takiuchi, H; Tamura, T; Yamaguchi, K	1
Afchain, P; André, T; de Gramont, A; Segura, C	1
Kang, BY; Kim, HA; Kim, KH; Lee, RA	1
Fujimoto-Ouchi, K; Mori, K; Onuma, E; Shirane, M; Tanaka, Y	1
Chilcott, J; Eggington, S; Paisley, S; Pandor, A; Saunders, M; Seymour, M; Sutcliffe, P; Tappenden, P	1
Eggington, S; Paisley, S; Pandor, A; Sutcliffe, P; Tappenden, P	1
Alomar, A; Dalmau, J; Fernández-Figueras, MT; Peramiquel, L; Puig, L; Roé, E	1
Peters, GJ; Prins, HJ; Temmink, OH; van Gelderop, E	1
Cartwright, T; de Braud, F; Figer, A; Haller, DG; Hill, M; Lim, R; Maroun, J; McKendrick, J; Nowacki, MP; Park, YS; Price, T; Schmoll, HJ; Sirzén, F; Soler-Gonzalez, G; Tabernero, J; Topham, C; Van Cutsem, E	1
Twelves, CJ	1
Fakih, MG; Reddy, N; Yu, J	1
Wils, J	1
André, T; de Gramont, A; Larsen, AK; Louvet, C; Tournigand, C	1
Tavares-Bello, R	1
Chau, KK; Choy, TS; Fu, YT; Law, CC; So, PF; Wong, KH	1
Gibson, DE; Szetela, AB	1
Alami, N; Belanger, S; Grieshaber, CK; Juste, S; Leyland-Jones, B; Paterson, J	1
Alexander, S; Dodds, M; Guichard, SM; Jodrell, DI; Macpherson, JS; Mayer, I; Muir, M; Reid, E	1
Douillard, JY; Dufour, P; Husseini, F; Lafuma, A; Maes, P; Perrocheau, G; Seitz, JF; Tilleul, P; Ychou, M	1
Beretta, GD; Labianca, R; Milesi, L; Mosconi, S; Pessi, MA; Quadri, A	1
Diasio, RB; Ledbetter, L; Saif, MW; Tomita, M	1
Cassidy, J; Glen, H	1
Akiyama, S; Fukushima, M; Oka, T; Ooyama, A; Yamamoto, M; Zhao, HY	1
Fukase, Y; Ishikawa, T; Ishitsuka, H; Nishida, M; Sawada, N; Yoshikubo, T	1
McCann, J	1
Timmerman, D	1
Maeda, Y; Sasaki, T	1
Seitz, JF	1
Horii, I; Ishikawa, T; Ishitsuka, H; Kato, Y; Sugiyama, Y; Tsukamoto, Y; Ura, M	1

Reviews

41 review(s) available for capecitabine and Colonic Neoplasms

Article	Year
Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature. World journal of surgical oncology, 2021, Nov-22, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Gastrointestinal Hemorrhage; Humans; Ileum; Male; Middle Aged; Prognosis	2021
Literature review of imaging, pathological diagnosis, and outcomes of metachronous lung and pancreatic metastasis of cecal cancer. World journal of surgical oncology, 2022, Oct-17, Volume: 20, Issue:1 Topics: Aged; Capecitabine; Carcinoembryonic Antigen; Cecal Neoplasms; Colonic Neoplasms; Humans; Lung; Male; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Rectal Neoplasms	2022
Colorectal cancer with testicular metastasis: A case report and literature review. Medicine, 2023, Mar-17, Volume: 102, Issue:11 Topics: Adenocarcinoma; Bevacizumab; Capecitabine; Colonic Neoplasms; Humans; Male; Middle Aged; Testicular Neoplasms	2023
Carbohydrate polymers-based surface modified nano delivery systems for enhanced target delivery to colon cancer - A review. International journal of biological macromolecules, 2023, Dec-31, Volume: 253, Issue:Pt 2 Topics: Capecitabine; Chitosan; Colonic Neoplasms; Delayed-Action Preparations; Humans; Nanoparticle Drug Delivery System; Polymers	2023
Adjuvant chemotherapy in colon cancer: state of the art and future perspectives. Current opinion in oncology, 2020, Volume: 32, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Circulating Tumor DNA; Colonic Neoplasms; Fluorouracil; Humans; Neoplasm Staging; Oxaliplatin; Randomized Controlled Trials as Topic	2020
Development of a Model for Predicting Early Discontinuation of Adjuvant Chemotherapy in Stage III Colon Cancer. JCO clinical cancer informatics, 2020, Volume: 4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Humans; Organoplatinum Compounds	2020
Psoriasis aggravation due to capecitabine: A case study and review of the literature. The Australasian journal of dermatology, 2018, Volume: 59, Issue:3 Topics: Adenocarcinoma; Capecitabine; Colonic Neoplasms; Disease Progression; Humans; Male; Middle Aged; Prognosis; Psoriasis; Risk Assessment	2018
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice? International journal of cancer, 2018, 11-15, Volume: 143, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Oxaliplatin; Randomized Controlled Trials as Topic	2018
The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More? Oncology (Williston Park, N.Y.), 2018, 09-15, Volume: 32, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Leucovorin; Medication Therapy Management; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Time Factors; Treatment Outcome	2018
[A Case of Colon Cancer with DPD Deficiency That Showed Severe Myelosuppression by CapeOX Adjuvant Chemotherapy after Colon Resection]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Female; Humans; Middle Aged; Myeloid Cells; Oxaliplatin	2018
[Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?] Bulletin du cancer, 2019, Volume: 106, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Immunotherapy; Leucovorin; Lymphocytes, Tumor-Infiltrating; Microsatellite Instability; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Phenotype; Prognosis; Pyrimidines	2019
Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer: A Systematic Review and Meta-analysis. JAMA network open, 2019, 05-03, Volume: 2, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Leucovorin; Neoplasm Staging; Observational Studies as Topic; Organoplatinum Compounds; Oxaliplatin; Progression-Free Survival; Randomized Controlled Trials as Topic; Time Factors	2019
Applications of oral fluoropyrimidines in colon cancer: their role and new directions. Journal of the National Comprehensive Cancer Network : JNCCN, 2003, Volume: 1 Suppl 3 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Oxaloacetates; Oxonic Acid; Tegafur; Uracil	2003
[A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11 Topics: Aged; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Dihydropyrimidine Dehydrogenase Deficiency; Fatal Outcome; Fluorouracil; Humans; Male; Neutropenia; Thrombocytopenia	2013
[Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:10 Topics: Acute Disease; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Early Diagnosis; Female; Fluorouracil; Humans; Leukoencephalopathies; Middle Aged	2014
[A case of juvenile colon cancer with peritoneal dissemination treated effectively by use of resection and chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colostomy; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Male; Oxaloacetates; Peritoneal Neoplasms	2014
Adjuvant chemotherapy for colon cancer: the difference between Japanese and western strategies. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Japan; Leucovorin; Lymph Node Excision; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates	2016
[A Case of Intussusception Caused by Descending Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Descending; Colonic Diseases; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Intussusception; Male; Middle Aged; Oxaloacetates	2016
Colon cancer: update on adjuvant therapy. Clinical colorectal cancer, 2008, Volume: 7, Issue:3 Topics: Age Factors; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic	2008
The role of capecitabine in the management of tumors of the digestive system. Reviews on recent clinical trials, 2009, Volume: 4, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cholangiocarcinoma; Colonic Neoplasms; Deoxycytidine; Digestive System Neoplasms; Docetaxel; Esophageal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Irinotecan; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A	2009
Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fatigue; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypertension; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Proteins; Rectal Neoplasms; Retrospective Studies; Vascular Endothelial Growth Factor A	2010
Evolving treatment of advanced colon cancer. Annual review of medicine, 2009, Volume: 60 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fluorouracil; Humans; Irinotecan; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin	2009
Capecitabine-induced severe hypertriglyceridaemia and diabetes: a case report and review of the literature. Diabetic medicine : a journal of the British Diabetic Association, 2009, Volume: 26, Issue:12 Topics: Antimetabolites, Antineoplastic; Blood Glucose; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fenofibrate; Fluorouracil; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Treatment Outcome	2009
Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Acidosis, Renal Tubular; Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Female; Fluid Therapy; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Potassium; Treatment Outcome	2010
[Adjuvant therapy in colon cancer]. Onkologie, 2010, Volume: 33 Suppl 4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Microsatellite Instability; Neoplasm Staging; Oxaloacetates; Prognosis	2010
[Difference of colon cancer and rectal cancer-from the view of an oncological physician]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Chromosomal Instability; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Microsatellite Instability; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Prognosis; Rectal Neoplasms; Risk Factors	2010
[Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Semustine; Survival Rate; Vincristine	2010
[Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:10 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Recurrence	2011
[Chemotherapy for colon cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 7 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Tegafur; Treatment Outcome; Uracil	2003
Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2004, Volume: 8 Suppl 1 Topics: Alopecia; Ambulatory Care; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Drug Administration Schedule; Drug Monitoring; Fluorouracil; Home Care Services; Humans; Nausea; Neutropenia; Nurse's Role; Oncology Nursing; Patient Education as Topic; Safety; Stomatitis; Survival Rate; Treatment Outcome	2004
Advances in colon cancer chemotheapy: nursing implications. Home healthcare nurse, 2005, Volume: 23, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colonic Neoplasms; Community Health Nursing; Deoxycytidine; Drug Monitoring; Fluorouracil; Home Infusion Therapy; Humans; Irinotecan; Nurse's Role; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Treatment Outcome	2005
Adjuvant therapy in colon cancer: which treatment in 2005? Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16 Suppl 4 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Survival Rate	2005
Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data. Critical reviews in oncology/hematology, 2006, Volume: 58, Issue:1 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Geriatrics; Humans; Male; Medical Oncology; Quality of Life	2006
[Adjuvant treatment of colorectal cancer]. Bulletin du cancer, 2006, Volume: 93, Issue:7 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Irinotecan; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Tegafur; Uracil	2006
Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. British journal of cancer, 2006, Nov-06, Volume: 95, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Survival Analysis	2006
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health technology assessment (Winchester, England), 2006, Volume: 10, Issue:41 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome; United Kingdom	2006
Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness. Clinical colorectal cancer, 2006, Volume: 6, Issue:4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Clinical Trials as Topic; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Neoplasm Staging	2006
Adjuvant treatment of colon cancer: past, present and future. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:2 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Survival Rate	2007
How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate. The American journal of nursing, 2007, Volume: 107, Issue:12 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Oncology Nursing; Patient Education as Topic; Prescription Fees	2007
The role of adjuvant chemotherapy in colon cancer. Surgical oncology, 2007, Volume: 16 Suppl 1 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin	2007
[Capecitabine--a review of its antitumor activity and toxicity in clinical studies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Randomized Controlled Trials as Topic; Rectal Neoplasms	2000

Trials

62 trial(s) available for capecitabine and Colonic Neoplasms

Article	Year
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217). Clinical colorectal cancer, 2022, Volume: 21, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Circulating Tumor DNA; Colonic Neoplasms; Colorectal Neoplasms; Disease-Free Survival; Humans; Neoplasm Staging; Oxaliplatin	2022
Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study. The European journal of health economics : HEPAC : health economics in prevention and care, 2022, Volume: 23, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Fluorouracil; Humans; Neoplasm Recurrence, Local; Quality-Adjusted Life Years	2022
The Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-label, Randomized, Phase III Trial. Annals of surgery, 2022, 05-01, Volume: 275, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Neoplasm Staging	2022
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 10-10, Volume: 40, Issue:29 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Prospective Studies	2022
Oxaliplatin (3 months Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 11-20, Volume: 40, Issue:33 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin	2022
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Frailty; Humans; Leucovorin; Neoplasm Staging; Oxaliplatin	2023
Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US. Oncology (Williston Park, N.Y.), 2022, 10-07, Volume: 36, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Circulating Tumor DNA; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm, Residual; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Prospective Studies	2022
Trifluridine-tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study. The lancet. Gastroenterology & hepatology, 2023, Volume: 8, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Female; Humans; Male; Rectal Neoplasms; Trifluridine	2023
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer. Clinical colorectal cancer, 2023, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cetuximab; Colonic Neoplasms; Colorectal Neoplasms; Disease-Free Survival; Humans; Mutation; Oxaliplatin; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Rectal Neoplasms; Retrospective Studies	2023
Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II trial. BMJ open, 2023, 01-31, Volume: 13, Issue:1 Topics: Capecitabine; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Humans; Neoadjuvant Therapy; Oxaliplatin; Prospective Studies; Quality of Life	2023
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study. BMC cancer, 2023, Jul-18, Volume: 23, Issue:1 Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Microsatellite Repeats; Multicenter Studies as Topic; Oxaliplatin; Randomized Controlled Trials as Topic; Rectal Neoplasms	2023
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. Scientific reports, 2019, 08-08, Volume: 9, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Multidrug Resistance-Associated Protein 2; Neoplasm Proteins; Organoplatinum Compounds; Oxaloacetates; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Sex Characteristics	2019
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial. JAMA oncology, 2019, 11-01, Volume: 5, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Oxaliplatin; Peripheral Nervous System Diseases	2019
Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study. BMC cancer, 2020, Aug-18, Volume: 20, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Chemotherapy, Adjuvant; Clinical Decision-Making; Colectomy; Colon; Colonic Neoplasms; Disease-Free Survival; Follow-Up Studies; Humans; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Oxaliplatin; Patient Selection; Practice Guidelines as Topic; Predictive Value of Tests; Prognosis; Prospective Studies; Registries; Risk Assessment	2020
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study. BMC cancer, 2020, Aug-20, Volume: 20, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Chemotherapy, Adjuvant; Circulating Tumor DNA; Colectomy; Colonic Neoplasms; Cost-Benefit Analysis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Liquid Biopsy; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Netherlands; Oxaliplatin; Patient Acceptance of Health Care; Practice Guidelines as Topic; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic	2020
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial. JAMA network open, 2020, 10-01, Volume: 3, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Proportional Hazards Models; Treatment Outcome	2020
Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2021, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Japan; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prospective Studies	2021
Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing. PloS one, 2020, Volume: 15, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Circulating Tumor DNA; Colonic Neoplasms; DNA Mutational Analysis; Female; Gene Frequency; High-Throughput Nucleotide Sequencing; Humans; Irinotecan; Liquid Biopsy; Male; Middle Aged; Oxaliplatin; Polymerase Chain Reaction; Proto-Oncogene Proteins p21(ras)	2020
Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer. Medicine, 2020, Dec-11, Volume: 99, Issue:50 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Omega-3; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Oxaliplatin; Peripheral Nervous System Diseases; Quality of Life; Surveys and Questionnaires	2020
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study). European journal of cancer (Oxford, England : 1990), 2021, Volume: 144 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxaliplatin; Prognosis; Survival Rate	2021
CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer. Cancer science, 2021, Volume: 112, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Circulating Tumor DNA; Colonic Neoplasms; Colorectal Neoplasms; Double-Blind Method; Humans; Japan; Neoplasm Recurrence, Local; Oxaliplatin; Prospective Studies; Pyrrolidines; Thymine; Trifluridine	2021
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. JNCI cancer spectrum, 2021, Volume: 5, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Life Expectancy; Male; Middle Aged; New Zealand; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Patient Preference; Prospective Studies; Surveys and Questionnaires; Survival Rate	2021
Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy. Acta oncologica (Stockholm, Sweden), 2018, Volume: 57, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Prognosis; Stromal Cells	2018
Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer. Drug metabolism and personalized therapy, 2017, 12-20, Volume: 32, Issue:4 Topics: Alleles; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genotype; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polymorphism, Genetic; Prospective Studies; Retrospective Studies; Thymidylate Synthase; Treatment Outcome; White People	2017
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial. Journal of surgical oncology, 2018, Volume: 117, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cohort Studies; Colonic Neoplasms; Female; Follow-Up Studies; Humans; Male; Neoplasm Invasiveness; Prognosis; Risk Factors; Stromal Cells; Survival Rate	2018
Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study). International journal of colorectal disease, 2018, Volume: 33, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Withholding Treatment	2018
A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer -ACTOR Study. Anticancer research, 2018, Volume: 38, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Diarrhea; Feasibility Studies; Female; Hand-Foot Syndrome; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Prospective Studies	2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer. The New England journal of medicine, 2018, Mar-29, Volume: 378, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Intention to Treat Analysis; Leucovorin; Male; Medication Adherence; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nervous System Diseases; Organoplatinum Compounds; Oxaliplatin; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Young Adult	2018
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 05-20, Volume: 36, Issue:15 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Italy; Leucovorin; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Time Factors; Treatment Outcome	2018
Safety and feasibility of home-based chemotherapy. Danish medical journal, 2018, Volume: 65, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cross-Over Studies; Feasibility Studies; Female; Home Care Services; Humans; Linear Models; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Patient Preference; Patient Safety; Quality of Life	2018
A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy. Surgery today, 2019, Volume: 49, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Digestive System Surgical Procedures; Disease-Free Survival; Female; Fluorouracil; Humans; Japan; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Proportional Hazards Models; Risk Factors; Time Factors; Withholding Treatment	2019
Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study. Cancer, 2013, Oct-01, Volume: 119, Issue:19 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Treatment Outcome	2013
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controll The Lancet. Oncology, 2014, Volume: 15, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Survival Rate; Young Adult	2014
Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial. Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:10 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Class I Phosphatidylinositol 3-Kinases; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Male; Mutation; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Radiography; Survival Rate; Treatment Outcome	2015
Computed tomography assessment of early response to neoadjuvant therapy in colon cancer. Danish medical journal, 2015, Volume: 62, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease Progression; Female; Humans; Lymph Nodes; Male; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm Invasiveness; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Treatment Outcome; Tumor Burden	2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-10, Volume: 33, Issue:32 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Proportional Hazards Models; Treatment Outcome	2015
PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:2 Topics: Activities of Daily Living; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Digestive System Surgical Procedures; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Quality of Life; Treatment Outcome	2016
Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection. European journal of cancer (Oxford, England : 1990), 2016, Volume: 59 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Case-Control Studies; Cetuximab; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Retrospective Studies; Survival Analysis	2016
[Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016, Volume: 192, Issue:7 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome	2016
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Patient Compliance	2016
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer. International journal of clinical oncology, 2017, Volume: 22, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Hand-Foot Syndrome; Humans; Male; Middle Aged; Treatment Outcome	2017
Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan. International journal of clinical oncology, 2017, Volume: 22, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Feasibility Studies; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Survival Rate	2017
[Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Proportional Hazards Models; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2008
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401. Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Quality of Life; Rectal Neoplasms; Survival Analysis; Time Factors	2009
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer. International journal of cancer, 2011, Feb-01, Volume: 128, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Treatment Outcome; Young Adult	2011
Safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors: results of a phase 1 trial. Journal of clinical pharmacology, 2011, Volume: 51, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Benzenesulfonates; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Fatigue; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib	2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Apr-10, Volume: 29, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Proportional Hazards Models	2011
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:4 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Dosage Calculations; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Quality of Life; Treatment Outcome	2012
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:5 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Hand-Foot Syndrome; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Pharmacokinetics; Pilot Projects; Prognosis; Treatment Outcome; Young Adult	2012
Comparison of pharmacokinetics and safety profiles of two capecitabine tablet formulations in patients with colon, colorectal or breast cancer. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:2 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Area Under Curve; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Cross-Over Studies; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Tablets; Therapeutic Equivalency	2013
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. The Lancet. Oncology, 2012, Volume: 13, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Young Adult	2012
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:12 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Peripheral Nervous System Diseases; Safety	2003
A pilot phase II study of capecitabine in advanced or recurrent colorectal cancer. Japanese journal of clinical oncology, 2004, Volume: 34, Issue:4 Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Hyperbilirubinemia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Rectal Neoplasms	2004
Efficacy of adjuvant capecitabine compared with bolus 5-fluorouracil/leucovorin regimen in dukes C colon cancer: results from the X-ACT trial. Clinical colorectal cancer, 2004, Volume: 4, Issue:2 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Neoplasm Staging; Treatment Outcome	2004
Capecitabine as adjuvant treatment for stage III colon cancer. The New England journal of medicine, 2005, Jun-30, Volume: 352, Issue:26 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Analysis	2005
Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis. Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hemolysis; Humans; Hyperbilirubinemia; Injections, Intravenous; Leucovorin; Middle Aged	2005
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial. Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diarrhea; Disease Progression; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Neutropenia; Prodrugs; Rectal Neoplasms; Remission Induction; Survival Rate; Topoisomerase I Inhibitors; Treatment Outcome	2005
Adjuvant capecitabine is at least as effective as fluorouracil plus leucovorin for survival in people with resected stage III colon cancer. Cancer treatment reviews, 2005, Volume: 31, Issue:8 Topics: Administration, Oral; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Male; Middle Aged; Survival Analysis; Treatment Outcome	2005
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. British journal of cancer, 2006, Apr-24, Volume: 94, Issue:8 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Drug Costs; Fluorouracil; Health Care Costs; Health Resources; Humans; Injections, Intravenous; Leucovorin; Neoplasm Staging; Quality of Life; Remission Induction; Sensitivity and Specificity; Survival Rate; Time Factors; Treatment Outcome; United Kingdom	2006
A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer. Japanese journal of clinical oncology, 2006, Volume: 36, Issue:7 Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Endpoint Determination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms	2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jan-01, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Research Design; Safety; Treatment Outcome	2007
Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer. Diseases of the colon and rectum, 2007, Volume: 50, Issue:12 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; China; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prodrugs; Prospective Studies; Survival Rate; Treatment Outcome	2007

Other Studies

230 other study(ies) available for capecitabine and Colonic Neoplasms

Article	Year
Capecitabine in combination with panitumumab is not the treatment of choice in older patients with metastatic colorectal cancer. Journal of geriatric oncology, 2022, Volume: 13, Issue:1 Topics: Aged; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Humans; Panitumumab	2022
Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study. International journal of cancer, 2022, 01-15, Volume: 150, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Oxaliplatin; Prospective Studies; Survival Rate	2022
Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals. JCO global oncology, 2021, Volume: 7 Topics: Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Fluorouracil; Hospitals, Public; Humans; Leucovorin; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; South Africa	2021
[A Case of Colon Cancer with Suspected DPD Deficiency Causing Severe Adverse Effects following Adjuvant Chemotherapy with Capecitabine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Female; Fluorouracil; Humans	2021
Efficacy and safety analysis of bevacizumab combined with capecitabine in the maintenance treatment of RAS-mutant metastatic colorectal cancer. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Carcinoembryonic Antigen; Colonic Neoplasms; Colorectal Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Rectal Neoplasms; Retrospective Studies	2022
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal Cancer. Clinical colorectal cancer, 2022, Volume: 21, Issue:3 Topics: Capecitabine; Cardiotoxicity; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Hand-Foot Syndrome; Humans; Prospective Studies; Rectal Neoplasms	2022
Conjunctivitis associated with capecitabine treatment in a patient with colon cancer: The importance on educating patients into identifying adverse reactions. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:8 Topics: Aged, 80 and over; Capecitabine; Colonic Neoplasms; Conjunctivitis; Fluorouracil; Humans; Male; Rectal Neoplasms	2022
Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer. Clinical colorectal cancer, 2022, Volume: 21, Issue:3 Topics: Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Genotype; Humans	2022
Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study. BMC cancer, 2022, Jul-21, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Longitudinal Studies; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Retrospective Studies	2022
Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer. Nutrients, 2022, Aug-17, Volume: 14, Issue:16 Topics: Amino Acids; Animals; Capecitabine; Colonic Neoplasms; Cysteine; Diet; Mice; Rectal Neoplasms	2022
Compound Capecitabine Colon-Targeted Microparticle Prepared by Coaxial Electrospray for Treatment of Colon Tumors. Molecules (Basel, Switzerland), 2022, Sep-03, Volume: 27, Issue:17 Topics: Capecitabine; Colon; Colonic Neoplasms; Delayed-Action Preparations; Drug Liberation; Humans; Particle Size	2022
Extracellular vesicle expansion of PMIS-miR-210 expression inhibits colorectal tumour growth via apoptosis and an XIST/NME1 regulatory mechanism. Clinical and translational medicine, 2022, Volume: 12, Issue:9 Topics: Animals; Apoptosis; Capecitabine; Caspase 3; Colonic Neoplasms; Colorectal Neoplasms; Extracellular Vesicles; Humans; Mice; MicroRNAs; NM23 Nucleoside Diphosphate Kinases; RNA, Long Noncoding	2022
Capecitabine plus oxaliplatin in the treatment of metastatic colorectal cancer at Tygerberg Hospital: a retrospective study. The Pan African medical journal, 2022, Volume: 42 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Hospitals; Humans; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Retrospective Studies	2022
Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer. International journal of biological macromolecules, 2022, Dec-01, Volume: 222, Issue:Pt A Topics: Capecitabine; Colonic Neoplasms; Humans; Macrophages; Phosphatidylinositol 3-Kinases; Toll-Like Receptor 4; Tumor Microenvironment	2022
Adjuvant 5-Fluorouracil/leucovorin, capecitabine, and oxaliplatin-related regimens for stage II/III colon cancer patients 66 years or older. Cancer medicine, 2023, Volume: 12, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Medicare; Neoplasm Staging; Oxaliplatin; United States	2023
Modulating the activity of fluoropyrimidines against colorectal cancer by Vitamin D and its analogs. Folia medica Cracoviensia, 2022, Sep-15, Volume: 62, Issue:3 Topics: Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Vitamin D	2022
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis. BMC cancer, 2022, Nov-01, Volume: 22, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Canada; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Testicular Neoplasms	2022
[Two Cases of Stage Ⅳ Colorectal Cancer with Long-Term Survival following Single-Agent Chemotherapy with Capecitabine-A Case Reports]. Gan to kagaku ryoho. Cancer & chemotherapy, 2022, Volume: 49, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Female; Fluorouracil; Humans; Male; Oxaliplatin	2022
[A Case of Rhabdomyolysis Caused by Oxaliplatin during Postoperative Adjuvant Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2023, Volume: 50, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Male; Middle Aged; Oxaliplatin; Rhabdomyolysis	2023
Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer. ESMO open, 2023, Volume: 8, Issue:2 Topics: Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Hand-Foot Syndrome; Humans; Immunologic Factors; Irinotecan	2023
The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival. International journal of clinical oncology, 2023, Volume: 28, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease Progression; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Postoperative Complications	2023
Amalgamation of quercetin with anastrozole and capecitabine: A novel combination to treat breast and colon cancers - An Journal of cancer research and therapeutics, 2023, Volume: 19, Issue:Supplement Topics: Anastrozole; Apoptosis; Capecitabine; Caspase 3; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Humans; Quercetin	2023
Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa. Cancer medicine, 2023, Volume: 12, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Fluorouracil; Humans; Neoplasm Staging; Oxaliplatin; South Africa	2023
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab. International journal of clinical oncology, 2023, Volume: 28, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Humans; Liver Neoplasms; Oxaliplatin; Rectal Neoplasms; Retrospective Studies; Treatment Outcome	2023
The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study. Current oncology (Toronto, Ont.), 2023, 07-06, Volume: 30, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies	2023
Changes in Prescribing Patterns in Stage III Colon Cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 2023, Volume: 21, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Oxaliplatin	2023
Long-term Survival after Treatment of Synchronous Isolated Right External Iliac Lymph Node Metastasis from Ascending Colon Cancer: A Case Report. The Kobe journal of medical sciences, 2023, Aug-21, Volume: 69, Issue:2 Topics: Aged; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Female; Humans; Ilium; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Oxaliplatin	2023
Estimating Treatment Effect of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer Using Bayesian Networks. JCO clinical cancer informatics, 2023, Volume: 7 Topics: Aged; Bayes Theorem; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Humans; Oxaliplatin	2023
Locust bean gum and sodium alginate based interpenetrating polymeric network microbeads encapsulating Capecitabine: Improved pharmacokinetics, cytotoxicity &in vivo antitumor activity. Materials science & engineering. C, Materials for biological applications, 2019, Volume: 104 Topics: Alginates; Animals; Antineoplastic Agents; Biopolymers; Capecitabine; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Galactans; Male; Mannans; Mice; Mice, Inbred BALB C; Microspheres; Particle Size; Plant Gums; Polymers; Rats; Rats, Wistar	2019
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience. Cancer communications (London, England), 2019, 10-16, Volume: 39, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; China; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Staging; Oxaloacetates; Prognosis; Young Adult	2019
Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study. Japanese journal of clinical oncology, 2020, Feb-17, Volume: 50, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Kidney; Male; Oxaliplatin; Product Surveillance, Postmarketing; Retrospective Studies; Risk Factors	2020
Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer. BMC cancer, 2020, Jan-28, Volume: 20, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Drug Therapy; Feasibility Studies; Female; Fluorouracil; Humans; Intestinal Obstruction; Laparoscopy; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Self Expandable Metallic Stents; Serum Albumin, Human; Treatment Outcome	2020
[A Case of Two Curative Resections for the Peritoneal Dissemination of Transverse Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Transverse; Colonic Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Peritoneal Neoplasms	2019
[A Case of Severe Aortic Thrombosis during the First Chemotherapy Regimen of CapeOX plus Bevacizumab for Metastatic Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Thrombosis	2020
Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China. Current oncology (Toronto, Ont.), 2020, Volume: 27, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Capecitabine; Chemotherapy, Adjuvant; China; Colonic Neoplasms; Coronavirus Infections; COVID-19; Disease Outbreaks; Drugs, Chinese Herbal; Hospitals; Humans; Neoplasm Staging; Organizational Policy; Oxaliplatin; Pandemics; Patient Selection; Pneumonia, Viral; Randomized Controlled Trials as Topic; SARS-CoV-2; Time-to-Treatment	2020
Impact of adjuvant therapy toxicity on quality of life and emotional symptoms in patients with colon cancer: a latent class analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Decision Making; Emotions; Female; Fluorouracil; Humans; Latent Class Analysis; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Physician-Patient Relations; Prospective Studies; Pyridines; Quality of Life; Spain	2021
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database. Journal of the National Cancer Institute, 2021, 04-06, Volume: 113, Issue:4 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Databases, Factual; Diarrhea; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Logistic Models; Male; Middle Aged; Nausea; Nervous System Diseases; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Sex Factors; Stomatitis; Thrombocytopenia; Vomiting	2021
Impact of Anatomic Extent of Nodal Metastasis on Adjuvant Chemotherapy Outcomes in Stage III Colon Cancer. Diseases of the colon and rectum, 2020, Volume: 63, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Prognosis; Retrospective Studies; Risk Factors; Survival Rate	2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. The Lancet. Oncology, 2020, Volume: 21, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors	2020
Impact of the IDEA Collaboration Study Results on Clinical Practice in France for Patients With Stage III Colon Cancer: A National GERCOR - PRODIGE Survey. Clinical colorectal cancer, 2021, Volume: 20, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; France; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Practice Patterns, Physicians'; Risk Assessment; Surveys and Questionnaires; Time Factors	2021
[A Case of BRAF-Mutated Obstructive Colon Cancer with Liver Metastases Treated with Multidisciplinary Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:13 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Female; Hepatectomy; Humans; Liver Neoplasms; Proto-Oncogene Proteins B-raf	2020
Association of the Collagen Signature in the Tumor Microenvironment With Recurrence and Survival of Patients With T4N0M0 Colon Cancer. Diseases of the colon and rectum, 2021, Volume: 64, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Colectomy; Collagen; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxaliplatin; Prognosis; Proportional Hazards Models; Second Harmonic Generation Microscopy; Tumor Microenvironment	2021
Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection. BMC cancer, 2021, Feb-19, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Quality of Life; Survival Rate; Treatment Outcome	2021
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. European journal of cancer (Oxford, England : 1990), 2021, Volume: 148 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Oxaliplatin; Prognosis; Survival Rate	2021
Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study. BMC cancer, 2021, May-03, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Hepatectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Prognosis; Proportional Hazards Models; Rectal Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Time Factors	2021
Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine-Based Chemotherapy in Patients With Early-Stage Colon Cancer. Clinical colorectal cancer, 2021, Volume: 20, Issue:4 Topics: Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Humans; Oxaliplatin; Retrospective Studies	2021
The Early Impact of the IDEA Collaboration Results: How the Results Changed Prescribing Practice. JNCI cancer spectrum, 2021, Volume: 5, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Drug Administration Schedule; Equivalence Trials as Topic; Female; Fluorouracil; Health Care Surveys; Humans; Leucovorin; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Practice Patterns, Physicians'; Risk	2021
Comparison between oxaliplatin therapy and capecitabine monotherapy for high-risk stage II - III elderly patients with colon cancer. Asian journal of surgery, 2022, Volume: 45, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Neoplasm Staging; Oxaliplatin	2022
Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study. World journal of surgical oncology, 2021, Aug-11, Volume: 19, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies	2021
[A Case of Advanced Transverse Colon Cancer with Nephrotic Syndrome Treated with Curative Resection and Complete Adjuvant Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Transverse; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Glomerulonephritis, Membranous; Humans; Laparoscopy; Nephrotic Syndrome; Oxaloacetates; Treatment Outcome	2017
Apoptosis and Caspase 3 Pathway Role on Anti-Proliferative Effects of Scrophulariaoxy Sepala Methanolic Extract on Caco-2 Cells. Drug research, 2017, Volume: 67, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caco-2 Cells; Capecitabine; Caspase 3; Cisplatin; Colonic Neoplasms; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; In Situ Nick-End Labeling; Inhibitory Concentration 50; Methanol; Plant Extracts; Scrophularia	2017
Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2018, Volume: 24, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies	2018
A Case of Capecitabine-induced Hyperammonemia in a Patient with Colon Cancer. Current drug safety, 2018, Volume: 13, Issue:1 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Female; Humans; Hyperammonemia; Middle Aged	2018
Long-term survival in a patient with low-level inflammatory markers and liver metastasis, converted resectable by TACE. Immunotherapy, 2017, Volume: 9, Issue:13 Topics: Adenocarcinoma; Adult; Biomarkers; Camptothecin; Capecitabine; Chemoembolization, Therapeutic; Colectomy; Colonic Neoplasms; Fluorouracil; Hepatectomy; Humans; Inflammation Mediators; Irinotecan; Leucovorin; Liver Neoplasms; Male; Microspheres; Organoplatinum Compounds; Oxaliplatin; Remission Induction	2017
Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school. BMC cancer, 2017, Oct-17, Volume: 17, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brazil; Capecitabine; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Hospitals, Public; Humans; Models, Theoretical; Neoplasm Metastasis; Oxaloacetates; Treatment Outcome	2017
Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:2 Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cerebellar Ataxia; Colonic Neoplasms; Humans; Male; Neurotoxicity Syndromes; Oxaliplatin	2019
[A Case of Ascending Colon Cancer with Lynch Syndrome Who Underwent XELOX Adjuvant Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colon, Ascending; Colonic Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; Deoxycytidine; Fluorouracil; Humans; Male; Oxaloacetates; Pedigree	2018
[A Case of Synchronous Multiple Liver Metastases from Ascending Colon Cancer Showing Pathological Complete Response to CapeOX Treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colectomy; Colon, Ascending; Colonic Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin	2017
Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer. Clinical colorectal cancer, 2018, Volume: 17, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies	2018
Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation. Drug development and industrial pharmacy, 2018, Volume: 44, Issue:10 Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Capecitabine; Carcinogens; Cell Survival; Colonic Neoplasms; Cytotoxins; Drug Carriers; HT29 Cells; Humans; Lipids; Male; Nanoparticles; Rats; Rats, Wistar; X-Ray Diffraction	2018
Polymorphisms in the ICOS/CD28-ICOSL pathway are related to capecitabine-based chemotherapy response in advanced colon cancer patients. Molecular immunology, 2018, Volume: 96 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Female; Genotype; History, 17th Century; Humans; Inducible T-Cell Co-Stimulator Ligand; Inducible T-Cell Co-Stimulator Protein; Male; Oxaliplatin; Polymorphism, Single Nucleotide	2018
Posterior Reversible Encephalopathy Syndrome after a Variety of Combined Chemotherapies Containing Bevacizumab for Metastatic Colon Cancer. Internal medicine (Tokyo, Japan), 2018, Aug-15, Volume: 57, Issue:16 Topics: Adult; Antineoplastic Agents, Immunological; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Female; Humans; Irinotecan; Leucovorin; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Posterior Leukoencephalopathy Syndrome; Treatment Outcome	2018
Secondary mania following cancer chemotherapy with capecitabine. BMJ case reports, 2018, Mar-28, Volume: 2018 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Capecitabine; Colonic Neoplasms; Humans; Male; Middle Aged; Olanzapine; Organoplatinum Compounds; Oxaliplatin	2018
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study. Clinical colorectal cancer, 2018, Volume: 17, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Chemotherapy, Adjuvant; Colon; Colonic Neoplasms; Comorbidity; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Progression-Free Survival; Rectal Neoplasms; Rectum; Retrospective Studies	2018
[A Case of Locally Advanced Pancreatic Cancer Successfully Resected after S-1 Therapy in an Elderly Patient]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Female; Humans; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome	2018
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer. European journal of cancer (Oxford, England : 1990), 2018, Volume: 96 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Decision-Making; Colonic Neoplasms; Databases, Factual; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Neoplasm Staging; Oxaliplatin; Risk Factors; Time Factors; Treatment Outcome	2018
Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer. British journal of cancer, 2018, Volume: 119, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Prognosis; Stromal Cells	2018
Capecitabine encapsulated chitosan succinate-sodium alginate macromolecular complex beads for colon cancer targeted delivery: in vitro evaluation. International journal of biological macromolecules, 2018, Oct-01, Volume: 117 Topics: Alginates; Animals; Capecitabine; Capsules; Cecum; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Rats; Temperature	2018
Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer. Clinical colorectal cancer, 2018, Volume: 17, Issue:3 Topics: Adenocarcinoma; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Registries; Treatment Outcome	2018
A molecular basis for the synergy between 17‑allylamino‑17‑demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression. Gene, 2019, Feb-05, Volume: 684 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Camptothecin; Capecitabine; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gene Expression; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Irinotecan; Lactams, Macrocyclic; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A	2019
Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study. International journal of colorectal disease, 2019, Volume: 34, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Risk Factors; Treatment Outcome	2019
[A Super-Elderly Patient with Recurrent Colon Cancer with Metastasis Effectively Treated with Capecitabine plus Bevacizumab Chemotherapy-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Female; Fluorouracil; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds	2018
[A Case That Was Complicated with Pulmonary Artery Thrombosis during Chemotherapy of the Regimen of CapeOX plus Bevacizumab against Recurrence of Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Pulmonary Artery; Thrombosis	2018
Long-term survival of an elderly female with metastatic colon cancer after treated with capecitabine monotherapy: A case report. Medicine, 2019, Volume: 98, Issue:5 Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Treatment Outcome	2019
Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer. The Journal of international medical research, 2019, Volume: 47, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxaliplatin; Prognosis; Retrospective Studies; Survival Rate	2019
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant. Medicine, 2019, Volume: 98, Issue:21 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Oxaloacetates	2019
[A Case of Pancreatic Metastasis from Colon Cancer Successfully Treated with Capecitabine/Oxaliplatin plus Bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxaliplatin; Pancreatic Neoplasms	2019
Optimal duration of adjuvant therapy for stage III colon cancer. Clinical advances in hematology & oncology : H&O, 2019, Volume: 17, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Fluorouracil; Guideline Adherence; Humans; Leucovorin; Levamisole; Meta-Analysis as Topic; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Prognosis; Prospective Studies; Risk; Treatment Outcome	2019
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (I Annals of oncology : official journal of the European Society for Medical Oncology, 2019, 08-01, Volume: 30, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Disease-Free Survival; Duration of Therapy; Female; Fluorouracil; Follow-Up Studies; Greece; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Patient Selection; Survival Rate; Time Factors; Young Adult	2019
Cost analysis of adjuvant therapy with XELOX or FOLFOX4 for colon cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; China; Colonic Neoplasms; Cost of Illness; Deoxycytidine; Female; Fluorouracil; Hospitalization; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaloacetates; Retrospective Studies; Treatment Outcome	2013
[Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged	2013
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule. Internal and emergency medicine, 2013, Volume: 8, Issue:5 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dihydropyrimidine Dehydrogenase Deficiency; Dose-Response Relationship, Drug; Fluorouracil; Head and Neck Neoplasms; Heterozygote; Humans; Male; Mutation; Patient Selection; Polymerase Chain Reaction	2013
[A case of relapsed colon cancer successfully treated by capecitabine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Sigmoid Neoplasms; Splenic Neoplasms	2013
[A case of metastatic colon cancer effectively treated by XELOX and IRIS]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Oxaloacetates; Oxonic Acid; Tegafur; Tomography, X-Ray Computed	2013
Paraneoplastic stiff person syndrome associated with colon cancer misdiagnosed as idiopathic Parkinson's disease worsened after capecitabine therapy. World journal of surgical oncology, 2013, Sep-12, Volume: 11 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnostic Errors; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Middle Aged; Parkinson Disease; Prognosis; Stiff-Person Syndrome	2013
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24 Suppl 6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 18; Colonic Neoplasms; Colonoscopy; Deoxycytidine; Early Detection of Cancer; Europe; Female; Fluorouracil; Follow-Up Studies; Humans; Intestinal Mucosa; Leucovorin; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Occult Blood; Organoplatinum Compounds; Oxaloacetates; Risk; Risk Assessment; Risk Factors; Sigmoidoscopy; Treatment Outcome	2013
[A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Oxaloacetates; Peritoneal Neoplasms	2013
[Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:8 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Hypertension; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Proteinuria; Rectal Neoplasms; Remission Induction; Young Adult	2013
[A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Recurrence	2013
Retrospective comparison of CAPOX and FOLFOX dose intensity, toxicity, and clinical outcomes in the treatment of metastatic colon cancer. Journal of gastrointestinal cancer, 2014, Volume: 45, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Survival Rate	2014
[A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Ascending; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Endocrine Gland Neoplasms; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin	2014
Colon carcinoma treated with oxaliplatin and capecitabine in a 12-year-old child. World journal of pediatrics : WJP, 2014, Volume: 10, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Child; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Oxaloacetates	2014
CAPOX associated with toxicities of higher grade but improved disease-free survival when compared with FOLFOX in the adjuvant treatment of stage III colon cancer. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Survival Rate	2014
To treat or not to treat: who should decide? The oncologist, 2014, Volume: 19, Issue:4 Topics: Aged; Capecitabine; Colonic Neoplasms; Decision Making; Deoxycytidine; Fluorouracil; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Patient Participation; Quality of Life; Treatment Refusal	2014
Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer. Cancer letters, 2014, Jul-28, Volume: 349, Issue:2 Topics: Administration, Metronomic; Animals; Antimetabolites, Antineoplastic; Capecitabine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; HCT116 Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Random Allocation; Thrombospondin 1; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2014
Increased mean corpuscular volume of red blood cells in patients treated with capecitabine for advanced breast and colon cancer. Chemotherapy, 2013, Volume: 59, Issue:5 Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Erythrocyte Indices; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Treatment Outcome	2013
Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings. World journal of surgical oncology, 2014, May-10, Volume: 12 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Tegafur; Uracil; Young Adult	2014
Colon cancer, version 3.2014. Journal of the National Comprehensive Cancer Network : JNCCN, 2014, Volume: 12, Issue:7 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fluorouracil; GTP Phosphohydrolases; Humans; Leucovorin; Liver Neoplasms; Membrane Proteins; Organoplatinum Compounds; Oxaloacetates; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Treatment Outcome	2014
Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Liver Cirrhosis; Liver Neoplasms; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin	2014
Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Canada; Capecitabine; Chemotherapy, Adjuvant; Choice Behavior; Colonic Neoplasms; Comorbidity; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Leucovorin; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Patient Preference; Retrospective Studies; Survival Rate; Vitamin B Complex	2014
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus. Clinical colorectal cancer, 2014, Volume: 13, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asia; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Drug Combinations; ErbB Receptors; Fluorouracil; Guideline Adherence; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Metastasectomy; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Oxonic Acid; Panitumumab; Practice Guidelines as Topic; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed	2014
Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer. BMJ case reports, 2014, 09-22, Volume: 2014 Topics: Adult; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Coronary Angiography; Coronary Thrombosis; Coronary Vasospasm; Deoxycytidine; Drug Therapy, Combination; Electrocardiography; Female; Fluorouracil; Humans; Organoplatinum Compounds; Oxaliplatin	2014
[Survey of the current status of capecitabine-induced hypertriglyceridemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:9 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Hypertriglyceridemia; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms	2014
[Capecitabine-induced subacute cutaneous lupus: a case report]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:10 Topics: Adverse Drug Reaction Reporting Systems; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Female; Fluorouracil; France; Humans; Lupus Erythematosus, Cutaneous; Middle Aged	2014
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand. Expert review of pharmacoeconomics & outcomes research, 2015, Volume: 15, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Female; Fluorouracil; Humans; Leucovorin; Male; Markov Chains; Middle Aged; Neoplasm Staging; Quality-Adjusted Life Years; Thailand	2015
Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2015, Volume: 17, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Rectal Neoplasms; Retreatment; Retrospective Studies; Survival Rate	2015
Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials. World journal of gastroenterology, 2014, Dec-21, Volume: 20, Issue:47 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; China; Clinical Trials as Topic; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Drug Costs; Female; Fluorouracil; Humans; Leucovorin; Male; Markov Chains; Middle Aged; Models, Economic; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Quality-Adjusted Life Years; Time Factors; Treatment Outcome	2014
XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Camptothecin; Capecitabine; Carcinoma; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oxaloacetates; Retrospective Studies; Treatment Outcome	2014
[Blindness and symmetrical neurological deficit in a patient with colon cancer receiving adjuvant chemotherapy: is it always cancer?]. Harefuah, 2014, Volume: 153, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Blindness; Brain Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Posterior Leukoencephalopathy Syndrome; Seizures; Steroids	2014
Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival. Cancer science, 2015, Volume: 106, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; beta-Thromboglobulin; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Receptors, CXCR4; Receptors, Interleukin-8B; Signal Transduction	2015
[Systemic chemotherapy and surgery for recurrent metachronous liver metastases with peritoneal dissemination from triple colon cancers-a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Oxaloacetates; Peritoneal Neoplasms; Recurrence	2014
Observational study of adjuvant therapy with capecitabine in colon cancer. Current medical research and opinion, 2015, Volume: 31, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Rectal Neoplasms; Retrospective Studies	2015
[Adjuvant chemotherapy with capecitabine for colon cancer - a case series]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Young Adult	2014
[A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Descending; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Middle Aged; Organoplatinum Compounds; Oxaliplatin	2014
[A case of metastatic gastric cancer originating from transverse colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Transverse; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Oxaloacetates; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms	2014
[A case of early gastric cancer completely responding to adjuvant chemotherapy for advanced colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colon, Ascending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms	2014
[The present status of CapeOX as adjuvant chemotherapy for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Rectal Neoplasms; Retrospective Studies	2015
Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:6 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Lymphatic Metastasis; Malaysia; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Postoperative Period; Prognosis; Retrospective Studies; Survival Rate; Young Adult	2015
Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndrome. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:2 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Electrocardiography; Heart Arrest; Humans; Male; Middle Aged; Syndrome; Ventricular Fibrillation	2016
Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity. PloS one, 2015, Volume: 10, Issue:4 Topics: Adult; Aged; Amidohydrolases; Antineoplastic Agents; Asian People; Capecitabine; Codon, Nonsense; Colonic Neoplasms; Female; Humans; Japan; Male; Middle Aged; Mutation, Missense; Pedigree; Polymorphism, Single Nucleotide; Uracil	2015
Toxicity Associated with Capecitabine in Patients Suffering from Dihydropyrimidine Dehydrogenase Deficiency. Chemotherapy, 2014, Volume: 60, Issue:5-6 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Dihydropyrimidine Dehydrogenase Deficiency; Fatal Outcome; Female; Humans	2014
Unilateral Capecitabine-related Hand-foot Syndrome. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:21 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hand-Foot Syndrome; Humans; Liver Neoplasms; Male; Middle Aged; Risk Factors; Syndrome	2015
Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report. The Pan African medical journal, 2015, Volume: 21 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Female; Hand-Foot Syndrome; Humans; Middle Aged	2015
Population-Based Cost-Minimization Analysis of CAPOX Versus Modified FOLFOX6 in the Adjuvant Treatment of Stage III Colon Cancer. Clinical colorectal cancer, 2016, Volume: 15, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; British Columbia; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Costs and Cost Analysis; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin	2016
Subacute cutaneous lupus erythematosus induced by capecitabine: 5-FU was innocent. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:11 Topics: Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Female; Fluorouracil; Humans; Lupus Erythematosus, Cutaneous	2016
Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma. European journal of medical research, 2015, Dec-02, Volume: 20 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Oxaloacetates; Retrospective Studies; ROC Curve	2015
Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study. Oncology research, 2014, Volume: 22, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Humans; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Risk Factors; Treatment Outcome	2014
Multiple inflammatory lesions in an oncology patient. International journal of dermatology, 2016, Volume: 55, Issue:12 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Drug Eruptions; Humans; Keratosis, Actinic; Liver Neoplasms; Male	2016
Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Management; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Incidence; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Patient Education as Topic; Quality of Life; Self Care; Young Adult	2016
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy. Oncology, 2016, Volume: 90, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Capecitabine; Chemotherapy, Adjuvant; Chronic Disease; Colonic Neoplasms; Diabetes Complications; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Prognosis	2016
[A Case of Colon Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine/Oxaliplatin plus Bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colectomy; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Prognosis	2015
[Validation of a questionnaire assessing patients' adherence and skill level of management for oral capecitabine treatment]. Bulletin du cancer, 2016, Volume: 103, Issue:3 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Discriminant Analysis; Female; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Psychometrics; Reproducibility of Results; Surveys and Questionnaires	2016
Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction. Journal of investigational allergology & clinical immunology, 2016, Volume: 26, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Desensitization, Immunologic; Drug Administration Schedule; Drug Eruptions; Humans; Hypersensitivity, Delayed; Immune Tolerance; Intradermal Tests; Male; Skin; Time Factors; Treatment Outcome	2016
The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:8 Topics: 5'-Nucleotidase; Animals; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Drug Monitoring; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Treatment Outcome	2016
Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients. European journal of cancer (Oxford, England : 1990), 2016, Volume: 61 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Multivariate Analysis; Netherlands; Organoplatinum Compounds; Oxaliplatin	2016
Compliance with adjuvant capecitabine in patients with stage II and III colon cancer: comparison of administrative versus medical record data. Cancer medicine, 2016, Volume: 5, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; British Columbia; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Drug Prescriptions; Female; Humans; Male; Medical Records; Medication Adherence; Middle Aged; Neoplasm Staging; Pharmaceutical Services	2016
Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2017, Volume: 19, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate	2017
The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study. Clinical colorectal cancer, 2017, Volume: 16, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Humans; Longitudinal Studies; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases	2017
[Comparison of the Cost-Effectiveness of the SOX and COX Regimens in Patients with Unresectable Advanced and Recurrent Colorectal Cancer Using a Clinical Decision Analysis Approach]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Drug Combinations; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Rectal Neoplasms; Recurrence; Tegafur	2016
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades. Annals of surgical oncology, 2017, Volume: 24, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cytoreduction Surgical Procedures; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Mucin-1; Neoadjuvant Therapy; Neoplasm, Residual; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2017
Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:6 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Drug Eruptions; Genital Diseases, Male; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasm Metastasis; Penile Diseases; Scrotum; Skin Ulcer	2017
[A Case of Hemodialysis Patients with Resected Synchronous Multiple Metastases from Colorectal Cancer Successfully Treated with CapeOX Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colectomy; Colonic Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin; Renal Dialysis	2016
[A Case of Aortoesophageal Fistula Rupture Due to Descending Thoracic Aortic Dissection with Recurrent Colon Cancer during Chemotherapy Containing Bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortic Diseases; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Esophageal Fistula; Fatal Outcome; Female; Fluorouracil; Humans; Oxaloacetates; Postoperative Complications; Recurrence	2016
[A Case Report of Clinical Complete Response with Chemotherapy for Descending Colon Cancer Complicated with Severe Pulmonary Dysfunction]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colon, Descending; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Lung Diseases; Male; Oxaloacetates; Pneumonectomy; Treatment Outcome	2016
[A Case of Laparoscopic Resection of a Lymph Node Recurrence after Surgery for Descending Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Descending; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Recurrence	2016
[A Case of Resection of Para-Aortic Lymph Node Recurrence Three Years after Curative Surgery for Ascending Colon Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bevacizumab; Capecitabine; Colon, Ascending; Colonic Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Recurrence; Time Factors	2016
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine. Clinical colorectal cancer, 2017, Volume: 16, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Retrospective Studies; Tegafur; Treatment Outcome; Uracil	2017
Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting. Clinical drug investigation, 2008, Volume: 28, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Female; Fluorouracil; Health Care Costs; Humans; Infusions, Parenteral; Italy; Leucovorin; Male; Middle Aged; National Health Programs; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Young Adult	2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatment. Onkologie, 2008, Volume: 31, Issue:8-9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Oxaloacetates; Treatment Failure; Treatment Outcome	2008
Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. Journal of Korean medical science, 2008, Volume: 23, Issue:5 Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Liver Neoplasms; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Remission Induction; Treatment Outcome	2008
Sequential or combination chemotherapy for a patient with mCRC? Cancer treatment reviews, 2008, Volume: 34 Suppl 2 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male	2008
Chemotherapy side-effect management using mobile phones. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2008, Volume: 2008 Topics: Adverse Drug Reaction Reporting Systems; Aged; Capecitabine; Cell Phone; Colonic Neoplasms; Deoxycytidine; Drug Therapy, Computer-Assisted; England; Female; Fluorouracil; Humans; Male; Middle Aged; Remote Consultation	2008
Oxaliplatin-mediated autoimmune thrombocytopenia. Clinical colorectal cancer, 2009, Volume: 8, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Purpura, Thrombocytopenic, Idiopathic	2009
Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Fatal Outcome; Fluorouracil; Gastrointestinal Hemorrhage; Hodgkin Disease; Humans; Immunohistochemistry; Lymph Nodes; Male; Oxaloacetates; Tomography, X-Ray Computed	2010
Assessing software impact on clinical workflow and resource utilization. Studies in health technology and informatics, 2009, Volume: 143 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Efficiency, Organizational; Evaluation Studies as Topic; Fluorouracil; Health Resources; Humans; Medical Oncology; Medication Systems, Hospital; Pharmacy Service, Hospital; Software	2009
Palmar-plantar hyperpigmentation with capecitabine in adjuvant colon cancer. Journal of gastrointestinal cancer, 2008, Volume: 39, Issue:1-4 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Hyperpigmentation; Male; Middle Aged	2008
Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:7 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fanconi Syndrome; Female; Fluorouracil; Humans; Irinotecan	2009
Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:9 Topics: Angina Pectoris; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Coronary Angiography; Coronary Vasospasm; Deoxycytidine; Diltiazem; Electrocardiography; Fluorouracil; Heart Rate; Humans; Male; Middle Aged; Tachycardia, Ventricular; Vasodilator Agents	2009
Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2009, Volume: 7, Issue:11 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Intestinal Perforation; Organoplatinum Compounds; Oxaliplatin; Risk Assessment; Stents	2009
Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan. PharmacoEconomics, 2009, Volume: 27, Issue:7 Topics: Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Female; Fluorouracil; Humans; Japan; Leucovorin; Male; Markov Chains; Middle Aged	2009
Cancer and chemotherapy. BMJ (Clinical research ed.), 2009, Aug-24, Volume: 339 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Interpersonal Relations; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Social Support	2009
The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. American journal of surgery, 2009, Volume: 198, Issue:3 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate; Tegafur; Treatment Outcome; Uracil	2009
[Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Child; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Intestinal Obstruction; Intestinal Perforation; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaloacetates; Proportional Hazards Models; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2009
[Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:9 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Camptothecin; Capecitabine; Carcinoembryonic Antigen; Child; Colonic Neoplasms; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Rectal Neoplasms; Remission Induction; Young Adult	2009
Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts. International journal of radiation oncology, biology, physics, 2009, Oct-01, Volume: 75, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Fluorouracil; HT29 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neural Networks, Computer; Organoplatinum Compounds; Oxaliplatin; Random Allocation; Time Factors; Transplantation, Heterologous; Treatment Outcome; Tumor Burden	2009
Sickle cell crisis in a patient receiving capecitabine chemotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 2010, Volume: 22, Issue:1 Topics: Adenocarcinoma; Anemia, Sickle Cell; Antineoplastic Agents, Phytogenic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Pain	2010
Atypical presentation of acute neurotoxicity secondary to oxaliplatin. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2010, Volume: 16, Issue:4 Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Leg; Middle Aged; Muscle Cramp; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Paresthesia; Treatment Outcome	2010
Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy. Yonsei medical journal, 2009, Dec-31, Volume: 50, Issue:6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Retrospective Studies; Syndrome	2009
MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy. Journal of cancer research and clinical oncology, 2010, Volume: 136, Issue:8 Topics: Amino Acid Substitution; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chromosome Mapping; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Female; Fluorouracil; Genotype; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prognosis; Rectal Neoplasms; Tumor Suppressor Proteins	2010
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer biology & therapy, 2010, Apr-01, Volume: 9, Issue:7 Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Capecitabine; Caspases; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; DNA Damage; Doxorubicin; Flow Cytometry; Fluorouracil; Glutamates; Guanine; Histones; Humans; Immunoenzyme Techniques; Mitomycin; Nuclear Proteins; Pemetrexed; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Rats; Rats, Inbred F344; Rats, Nude; Xenograft Model Antitumor Assays	2010
[Chemotherapy of colonic cancer]. Soins; la revue de reference infirmiere, 2010, Issue:743 Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds	2010
Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. European journal of cancer care, 2011, Volume: 20, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Medication Adherence; Middle Aged; Practice Patterns, Physicians'; Qualitative Research; Risk Factors	2011
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. British journal of cancer, 2010, Oct-26, Volume: 103, Issue:9 Topics: Aged; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cancer Vaccines; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Dendritic Cells; Deoxycytidine; Fluorouracil; Humans; Hypersensitivity, Delayed; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; T-Lymphocytes	2010
Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab. Archives of dermatology, 2011, Volume: 147, Issue:1 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Eruptions; Fluorouracil; Humans; Male; Melanoma; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms	2011
Capecitabine-induced, nonneutropenic enterocolitis. Journal of gastrointestinal cancer, 2011, Volume: 42, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Cecal Neoplasms; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Enterocolitis; Fluorouracil; Humans; Male; Middle Aged; Tomography, X-Ray Computed	2011
[A resected case of gastric regional lymph node metastasis from ascending colon cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colon, Ascending; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Remission Induction; Stomach Neoplasms	2011
Retinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resection. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxaloacetates; Retinal Vein Occlusion; Risk Factors; Vision Disorders	2012
Resolving actinic keratoses: an expected side-effect of capecitabine therapy. Clinical and experimental dermatology, 2012, Volume: 37, Issue:1 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Facial Dermatoses; Fluorouracil; Humans; Keratosis, Actinic; Male	2012
Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2011, Volume: 13, Issue:11 Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Oxaloacetates; Practice Guidelines as Topic; Spain	2011
Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cohort Studies; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Guideline Adherence; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Netherlands; Organoplatinum Compounds; Oxaliplatin; Practice Guidelines as Topic; Registries; Treatment Outcome; Young Adult	2012
Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients. International journal of clinical oncology, 2013, Volume: 18, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Prospective Studies	2013
[Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:3 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Follow-Up Studies; Hand-Foot Syndrome; Humans; Hyperpigmentation; Male; Remission, Spontaneous	2012
[Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Male; Middle Aged; Neoplasm Staging	2012
A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clinical and experimental nephrology, 2012, Volume: 16, Issue:3 Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prednisone; Thrombocytopenia	2012
Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Cancer biology & therapy, 2012, Volume: 13, Issue:9 Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Capecitabine; Carcinoma; Colonic Neoplasms; Deoxycytidine; Drug Synergism; Female; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Radiography; Recombinant Fusion Proteins; Thymidine Phosphorylase; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012
Colon carcinoma in a child treated with oxaliplatin and antiangiogenic treatment regimens. Pediatric hematology and oncology, 2012, Volume: 29, Issue:6 Topics: Adenocarcinoma; Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fatal Outcome; Female; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin	2012
Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer. International journal of colorectal disease, 2013, Volume: 28, Issue:6 Topics: Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Fluorouracil; Humans; Indoles; MicroRNAs; Neoplasm Metastasis; Pyrroles; Sunitinib; Treatment Outcome	2013
[Therapy traces on hands and feet in a patient with colon cancer]. MMW Fortschritte der Medizin, 2012, Jun-21, Volume: O 154 Suppl 2 Topics: Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Fluorouracil; Hand-Foot Syndrome; Humans; Liver Neoplasms; Male; Palliative Care	2012
Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Oxaliplatin; Prognosis; Rectal Neoplasms; Retrospective Studies; Survival Rate; Young Adult	2013
[Resolution of actinic keratosis with capecetabin]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:11 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Keratosis, Actinic; Male; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Neoplasms	2012
Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine? Hong Kong medical journal = Xianggang yi xue za zhi, 2012, Volume: 18, Issue:6 Topics: Administration, Oral; Adult; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Hypertriglyceridemia; Pancreatitis, Acute Necrotizing; Triglycerides	2012
Solitary bulky mediastinal lymph node metastasis from colon cancer. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2013, Volume: 19, Issue:4 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Cell Differentiation; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron-Emission Tomography; Reoperation; Thoracic Surgery, Video-Assisted; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
[A case of transverse colon cancer with multiple liver metastases and hepatic pedicle lymph node involvement showing pathological complete response by XELOX plus bevacizumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:13 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Transverse; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Oxaloacetates	2012
[Assessment of hand-foot syndrome in cancer outpatients undergoing chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39 Suppl 1 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hand-Foot Syndrome; Humans; Outpatients; Quality of Life	2012
Unsupported off-label chemotherapy in metastatic colon cancer. BMC health services research, 2012, Dec-29, Volume: 12 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Capecitabine; Cetuximab; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Insurance Claim Review; Middle Aged; Off-Label Use; Panitumumab; Practice Patterns, Physicians'; Retrospective Studies; United States	2012
Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Length of Stay; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Operative Time; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed	2013
NICE recommends new treatment for breast and bowel cancer. BMJ (Clinical research ed.), 2003, May-31, Volume: 326, Issue:7400 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Paclitaxel; Practice Guidelines as Topic; Taxoids; Tegafur; Uracil	2003
Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports. British journal of cancer, 2003, Aug-18, Volume: 89, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Aged; Anticonvulsants; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Interactions; Epilepsy, Generalized; Female; Fluorouracil; Humans; Male; Middle Aged; Phenytoin	2003
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. International journal of colorectal disease, 2004, Volume: 19, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Treatment Outcome	2004
Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy. Anti-cancer drugs, 2004, Volume: 15, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disabled Persons; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polyneuropathies; Severity of Illness Index	2004
Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. International journal of cancer, 2004, Oct-20, Volume: 112, Issue:1 Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Gastrointestinal Neoplasms; Green Fluorescent Proteins; Humans; Luminescent Proteins; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Rectal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Thymidine Phosphorylase; Transplantation, Heterologous	2004
Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis. International journal of gastrointestinal cancer, 2003, Volume: 34, Issue:2-3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Kidney Neoplasms; Leucovorin; Male; Neoplastic Cells, Circulating; Nephrectomy	2003
[Adjuvant therapy of colonic carcinoma--soon in tablet form]. Krankenpflege Journal, 2004, Volume: 42, Issue:5-6 Topics: Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Multicenter Studies as Topic; Prodrugs; Randomized Controlled Trials as Topic; Tablets; Treatment Outcome	2004
Synergistic antitumor activity of capecitabine in combination with irinotecan. Clinical colorectal cancer, 2005, Volume: 4, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Irinotecan; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Quinazolines; Thiophenes	2005
Importance of preclinical investigations of the integration of capecitabine into polychemotherapy regimens. Clinical colorectal cancer, 2005, Volume: 4, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorouracil; Irinotecan; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Quinazolines; Thiophenes	2005
Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Coronary Vasospasm; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged	2005
Adjuvant therapy for colon cancer--the pace quickens. The New England journal of medicine, 2005, Jun-30, Volume: 352, Issue:26 Topics: Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Neoplasm Staging	2005
Capecitabine-warfarin interaction. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:9 Topics: Anticoagulants; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Interactions; Fluorouracil; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Male; Middle Aged; Mitral Valve; Warfarin	2005
Capecitabine as third line therapy in patients with advanced colorectal cancer. Acta oncologica (Stockholm, Sweden), 2005, Volume: 44, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Carcinoembryonic Antigen; Colonic Neoplasms; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Prodrugs; Rectal Neoplasms; Retrospective Studies; Survival Rate	2005
[Adjuvant therapy of colon cancer soon in tablet form]. Krankenpflege Journal, 2005, Volume: 43, Issue:4-6 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Infusions, Intravenous; Neoplasm Staging	2005
Accrual delayed in adjuvant bevacizumab trial. Journal of the National Cancer Institute, 2006, Apr-05, Volume: 98, Issue:7 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cause of Death; Chemotherapy, Adjuvant; Colonic Neoplasms; Controlled Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin	2006
Acute coronary syndrome induced by capecitabine therapy. Heart, lung & circulation, 2006, Volume: 15, Issue:5 Topics: Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Coronary Angiography; Coronary Disease; Deoxycytidine; Diagnosis, Differential; Electrocardiography; Female; Fluorouracil; Humans; Middle Aged; Prodrugs	2006
Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species. World journal of gastroenterology, 2006, Sep-21, Volume: 12, Issue:35 Topics: Antimetabolites, Antineoplastic; Capecitabine; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Fluorouracil; Gene Expression Regulation, Neoplastic; Hemoglobins; HT29 Cells; Humans; Oxidative Stress; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Superoxide Dismutase	2006
Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:6 Topics: Animals; Cachexia; Capecitabine; Cell Line; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Hypercalcemia; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Parathyroid Hormone-Related Protein; Tumor Cells, Cultured; Weight Loss	2007
Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Suppl Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Erythema; Fluorouracil; Humans; Keratosis; Male; Paresthesia	2006
The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells. British journal of cancer, 2007, Jan-15, Volume: 96, Issue:1 Topics: Administration, Oral; Animals; Apoptosis; Capecitabine; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Floxuridine; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Pyrrolidines; Sensitivity and Specificity; Thymidine Phosphorylase; Thymine; Treatment Outcome; Trifluridine; Tumor Cells, Cultured; Uracil; Xenograft Model Antitumor Assays	2007
Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy. Clinical colorectal cancer, 2007, Volume: 6, Issue:5 Topics: Age Factors; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Leucovorin; Male; Rectal Neoplasms; Retrospective Studies; Survival; Treatment Outcome	2007
Adjuvant therapy for stage II and III colorectal cancer. Seminars in oncology, 2007, Volume: 34, Issue:2 Suppl 1 Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prodrugs; Rectal Neoplasms; Vitamin B Complex	2007
Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient. Journal of the European Academy of Dermatology and Venereology : JEADV, 2007, Volume: 21, Issue:10 Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Colonic Neoplasms; Deoxycytidine; Diagnosis, Differential; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Hyperpigmentation; Male; Vitiligo	2007
Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5 Topics: Aminoacridines; Animals; Antineoplastic Agents; Camptothecin; Capecitabine; Cell Line, Tumor; Cell Proliferation; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Fluorouracil; HT29 Cells; Humans; In Vitro Techniques; Irinotecan; Mice; Mice, Nude; Organoplatinum Compounds; Oxaliplatin; Paclitaxel	2007
Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:2 Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Capecitabine; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Gene Expression; Hepatocytes; Liver; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous	2008
Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting. Oncology, 2007, Volume: 72, Issue:3-4 Topics: Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Fluorouracil; France; Humans; Leucovorin; Treatment Outcome	2007
Capecitabine-related cardiotoxicity: recognition and management. The journal of supportive oncology, 2008, Volume: 6, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Heart Diseases; Humans; Incidence; Male; Middle Aged; Prodrugs; Rectal Neoplasms	2008
Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial. Expert review of anticancer therapy, 2008, Volume: 8, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Costs and Cost Analysis; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Rate	2008
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. Cancer letters, 2008, Aug-18, Volume: 267, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oxonic Acid; Tegafur; Thrombospondin 1; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2008
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Induction; Female; Fluorouracil; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Taxoids; Thymidine Phosphorylase; Transplantation, Heterologous; Tumor Necrosis Factor-alpha; Up-Regulation	1998
Colon cancer: new drug options improve on 5-FU. Journal of the National Cancer Institute, 1998, Jul-01, Volume: 90, Issue:13 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Folic Acid Antagonists; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Survival Analysis; Tegafur; Thiophenes; Thymidylate Synthase; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome	1998
Positive results achieved with new oral chemotherapy agent. Oncology nursing forum, 1999, Volume: 26, Issue:4 Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Oncology Nursing	1999
5-fluorouracil/leucovorin versus capecitabine in patients with stage III colon cancer. Seminars in oncology, 2001, Volume: 28, Issue:1 Suppl 1 Topics: Administration, Oral; Antineoplastic Agents; Capecitabine; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Multicenter Studies as Topic; Neoplasm Staging; Randomized Controlled Trials as Topic	2001
Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue b Biopharmaceutics & drug disposition, 2001, Volume: 22, Issue:1 Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Capecitabine; Colonic Neoplasms; Cytosol; Deoxycytidine; Dose-Response Relationship, Drug; Fluorouracil; Humans; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prodrugs; Subcellular Fractions; Therapeutic Equivalency; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001